documentId,Paragraph,Compound
US20150005279A1,"To a solution of 5-bromopyridin-2-ol (4 g, 23 mmol) in THF (200 mL) at about 0° C. was added NaH (0.83 g, 34.7 mmol) in portions. The reaction mixture was stirred at rt for about 15 min followed by addition of iodomethane (9.8 g, 69 mmol). The mixture was stirred overnight at rt. After the completion of the reaction (TLC monitoring), the reaction mixture was cooled to about 0° C., water was added, extracted with EtOAc (100 mL×2). The organic layer was washed with brine, dried with anhydrous Na2SO4, filtered and concentrated under reduced pressure to provide 5-bromo-1-methylpyridin-2-(1H)-one (3 g, 69%): 1H NMR (MeOD) δ 7.87 (s, 1H), 7.58-7.55 (m, 1H), 6.47 (d, J=9.6 Hz, 1H), 3.53 (s, 3H).",5-bromopyridin-2-ol | THF | NaH | iodomethane | water | EtOAc | brine | Na2SO4 | 5-bromo-1-methylpyridin-2-(1H)-one
US20090286790A1,"A solution of 5-nitro-3-(trifluoromethyl)benzoic acid (2.35 g, 10 mmol) and H2SO4 (53 μL, 1 mmol) in methanol (30 mL) is allowed to warm to reflux and stir for 20 hours. The mixture is cooled to room temperature, then the mixture is concentrated under reduced pressure. The obtained residue is neutralized with saturated aq. NaHCO3. The mixture is extracted with CH2Cl2. The combined organic layer is washed with brine, dried over Na2SO4, filtrated, and concentrated under reduced pressure to give 3-nitro-5-trifluoromethyl-benzoic acid methyl ester (2.15 g, 86%), which is used in the next step without further purification.",5-nitro-3-(trifluoromethyl)benzoic acid | H2SO4 | methanol | CH2Cl2 | brine | Na2SO4 | 3-nitro-5-trifluoromethyl-benzoic acid methyl ester
US20120295903A1,"To a solution of crude 10-(2-(benzylamino)ethyl)-7,8-dimethylbenzo[g]-pteridine-2,4(3H,10H)-dione (7.53 mmol) in MeOH (200 mL) is added di-tert-butyl dicarbonate (5.2 g, 23.8 mmol) and Et3N (4 mL). The reaction was concentrated under reduced pressure and purified via silica gel chromatography (ISCO) (100% DCM to 10% MeOH/DCM) over 1 h to obtain desired product (1.85 g, 54%) as a brown solid.","10-(2-(benzylamino)ethyl)-7,8-dimethylbenzo[g]-pteridine-2,4(3H,10H)-dione | MeOH | di-tert-butyl dicarbonate | Et3N | silica gel | DCM | MeOH/DCM | desired product"
US07026335B2,"To a cooled (−78° C.) solution of 4-(R)-methyl-5-(S)-phenyl-oxazolidin-2-one, 31, (600 mg, 3.39 mmol) in anhydrous tetrahydrofuran (20 mL) is added n-butyl lithium (2.5 mL, 1.6M solution in hexanes, 4.07 mmol). The resulting solution is stirred at −78° C. for ninety minutes and then 3-(4-chloro-phenyl)-propionyl chloride (894 mg, 4.41 mmol) is slowly added. The solution is warmed to room temperature for thirty minutes and then the solvents removed under reduced pressure. The crude product is purified over silica (20:80 ethyl acetate:hexanes, Rf˜0.3) to afford 1.07 g (92% yield) of the desired compound as a colorless solid. 1H NMR (CDCl3 300 MHz) δ 0.91 (d, J=6.6 Hz, 3H), 3.01 (t, J=7.8 Hz, 2H), 3.18–3.40 (m, 2H), 4.77 (m, 1H), 5.67 (d, J=7.2 Hz, 1H), 7.18–7.48 (m, 9H). MS (ESI) m/z 344 (M+H+)",4-(R)-methyl-5-(S)-phenyl-oxazolidin-2-one | tetrahydrofuran | n-butyl lithium | 3-(4-chloro-phenyl)-propionyl chloride | crude product | silica | desired compound
US09149475B2,"In a 100 mL round bottom flask to a solution of 2-chloro-5-fluoro-N-(2,2,6,6,-tetramethylpiperidin-4-yl)pyrimidin-4-amine (Compound 15; 0.18 g, 0.63 mmol) in 10 mL iPrOH, 4-cyclopropyl-3-(1H-tetrazol-1-yl)benzeneamine (0.18 g, 0.88 mmol) and TosOH (0.095 g, 0.50 mmol) were added. The reaction mixture was heated at 100° C. for 3 hours. LCMS analysis indicated the complete consumption of the mono-SNAr product and appearance of Compound III-118. The reaction mixture was then cooled to room temperature and volatiles were removed under reduced pressure. The crude reaction mixture was purified by column chromatography using DCM/2 M NH3 in MeOH to get tan solid that was further purified by tituration using DCM/hexanes.","2-chloro-5-fluoro-N-(2,2,6,6,-tetramethylpiperidin-4-yl)pyrimidin-4-amine | Compound 15 | iPrOH | 4-cyclopropyl-3-(1H-tetrazol-1-yl)benzeneamine | TosOH"
US20150072969A1,"Ethyl 2-(3-(4-((2′,6′-dimethyl-4′-((tetrahydrofuran-2-yl)methoxy)-[1,1′-biphenyl]-3-yl)methoxy)phenyl)oxetan-3-yl)acetate (compound of Step 1b of Example 46, 135 mg, 0.254 mM) was dissolved in a mixture of THF (4 ml) and MeOH (1 ml) and aqueous LiOH monohydrate (1018 μl, 1.526 mM) was added to the reaction mixture. The reaction mixture was stirred for 6 h and quenched with saturated NH4Cl. The mixture was extracted with ethyl acetate and the organic layer was washed with brine, dried over Na2SO4 and concentrated to afford the title compound 2-(3-(4-((2′,6′-dimethyl-4′-((tetrahydrofuran-2-yl)methoxy)-[1,1′-biphenyl]-3-yl)methoxy)phenyl)oxetan-3-yl)acetic acid (80 mg) as a white solid. Yield: 62.6%; 1H NMR (DMSO-d6, 300 MHz): δ 12.8 (s, 1H), 7.44-7.40 (m, 2H), 7.21-7.18 (m, 3H), 7.07 (d, J=7.2 Hz, 1H), 6.96 (d, J=8.7 Hz, 2H), 6.69 (s, 2H), 5.14 (s, 2H), 4.74 (s, 4H), 4.15-4.10 (m, 1H), 3.95-3.93 (m, 2H), 3.80-3.67 (m, 2H), 3.50-3.32 (m, 2H), 3.01 (s, 2H), 2.09-2.05 (m, s, 1.91, 7H), 1.80-1.74 (m, 1H); MS: m/z 525 (M+Na).","Ethyl 2-(3-(4-((2′,6′-dimethyl-4′-((tetrahydrofuran-2-yl)methoxy)-[1,1′-biphenyl]-3-yl)methoxy)phenyl)oxetan-3-yl)acetate | compound | THF | MeOH | LiOH monohydrate | NH4Cl | ethyl acetate | brine | Na2SO4 | title compound | 2-(3-(4-((2′,6′-dimethyl-4′-((tetrahydrofuran-2-yl)methoxy)-[1,1′-biphenyl]-3-yl)methoxy)phenyl)oxetan-3-yl)acetic acid"
US06825222B2,"A solution of 2-{4-[2-(2-biphenyl-3-yl-5-methyloxazol-4-yl)ethoxy]-3-butylphenoxy}-2-methylpropionic acid ethyl ester (0.57 mmol) in ethanol (10 mL) was treated with 2.5 N aqueous NaOH (1.1 mL), and heated at 55° C. for 2 h. The reaction was cooled to ambient temperature and concentrated down to near dryness. The residue was then diluted with ethyl acetate (40 mL) and water (20 mL) and acidified to pH=1 with 1N aqueous HCl. The organic layer was washed with brine (20 mL), dried (Na2SO4) and concentrated in vacuo to give 2-{4-[2-(2-biphenyl-4-yl-5-methyloxazol-4-yl)ethoxy]-3-butylphenoxy}-2-methylpropionic acid. 1H NMR (400 MHz, CDCl3) δ 8.2 (d, J=1.5 Hz, 1H), 7.95 (d, J=7.8 Hz, 1H), 7.66-7.63 (m, 3H), 7.52-7.35 (m, 4H), 6.73 (d, J=2.9 Hz, 3H), 4.20 (t, J=6.1 Hz, 2H), 3.02 (t, J=6.1 Hz, 2H), 2.52 (t, J=7.6 Hz, 2H), 2.40 (s, 3H), 1.51-1.42 (m, 8H), 1.29 (quintet, J=7.2 Hz, 2H), 0.86 (t, J=7.1 Hz, 3H); MS (ES) m/e 514 (M+1).",2-{4-[2-(2-biphenyl-3-yl-5-methyloxazol-4-yl)ethoxy]-3-butylphenoxy}-2-methylpropionic acid ethyl ester | ethanol | NaOH | ethyl acetate | water | brine | Na2SO4 | 2-{4-[2-(2-biphenyl-4-yl-5-methyloxazol-4-yl)ethoxy]-3-butylphenoxy}-2-methylpropionic acid
US06548526B2,"A mixture of (4-cyano-3-mercapto-isothiazol-5-yl)-carbamic acid phenyl ester (0.70 g, 2.5 mmol), 2,6-di-tert-butyl-4-methylphenol (BHT) (one crystal) and concentrated sulfuric acid (3 mL) was stirred for 18 hours at room temperature. The mixture was diluted with ice water, extracted 3× with ethyl acetate, and the combined organic layers were dried over Na2SO4, filtered and concentrated in vacuo. The residue was dissolved in 10 mL of ethanol at 0° C. and was treated with 0.096 g (2.5 mmol) of NaBH4. After stirring for 30 minutes, the mixture was acidified with 1 M HCl, extracted into ethyl acetate, dried over Na2SO4, filtered and concentrated in vacuo, affording 0.60 g (81%) of (4-carbamoyl-3-mercapto-isothiazol-5-yl)-carbamic acid phenyl ester as a yellow solid. 1H NMR (400 MHz, acetone-d6) δ 13.0 (s, 1H), 11.0-10.9 (bs, 1H), 10.3 (s, 1H), 7.47 (t, 2H, J=6.8 Hz), 7.37-7.30 (m, 4H) ppm; MS (APCl, m/z): 296 [M+H]−.","(4-cyano-3-mercapto-isothiazol-5-yl)-carbamic acid phenyl ester | 2,6-di-tert-butyl-4-methylphenol | sulfuric acid | ice water | ethyl acetate | Na2SO4 | ethanol | NaBH4 | HCl | ethyl acetate | Na2SO4 | (4-carbamoyl-3-mercapto-isothiazol-5-yl)-carbamic acid phenyl ester"
US09029295B2,"47% ethyl glyoxylate in toluene (polymer type) (467.84 g, 2.15 mol) was dissolved in THF (620 ml), to the solution was slowly added methylhydrazine (103 g, 1.02 eq) under ice-cooled. After the addition was complete, the mixture was stirred at 0° C. for 30 minutes and at room temperature for 16 hours. The reaction solution was concentrated under reduced pressure. The residue was dissolved in toluene (400 ml), and concentrated under reduced pressure. The resulting solid was washed with tert-butyl methyl ether (200 ml), and allowed to stand at 0° C. for 30 minutes. Then, the mixture was filtered, and washed with cooled tert-butyl methyl ether (100 ml) to give 223.91 g of Compound (XVI-1) (yield: 78.8%) as solid.",ethyl glyoxylate | toluene | THF | methylhydrazine | toluene | tert-butyl methyl ether | tert-butyl methyl ether | Compound
US04419524,"24.7 g. of 2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane-1-carboxylic acid ethyl ester (purity: 96%, cis)trans ratio: 40:60), 6.7 g. of a 30% aqueous potassium hydroxide solution and 0.05 g. of polyoxyethylenesorbitane monooleate are stirred at 70° C. for 60 minutes. Stirring is continued with a further 6-g. portion of the potassium hydroxide solution for 60 minutes and with an additional 6-g. portion for 120 minutes. The solution is diluted with 100 ml. of water and 40 ml. fraction is distilled off to remove volatile, non-hydrolyzed substances. To the residual aqueous solution 80 cm3 of hexane is added followed by the addition of 12 g. of a 36% aqueous hydrochloric acid solution at 60° C. with stirring. The reaction mixture is then further manufactured as described in Example 1. 19.8 g. (95%) of 2,2-dimethyl-3-(2,2-dichlorovinyl)cyclopropane-1-carboxylic acid are obtained. Cis/trans ratio: 40:60.","2,2-dimethyl-3-(2,2-dichlorovinyl)-cyclopropane-1-carboxylic acid ethyl ester | potassium hydroxide | monooleate | 6-g | potassium hydroxide | 6-g | water | hexane | hydrochloric acid | 2,2-dimethyl-3-(2,2-dichlorovinyl)cyclopropane-1-carboxylic acid"
US20090042875A1,"A stirred mixture of 4-bromo-2-ethoxy-1-methoxy-benzene (6.52 g, 23.7 mmol) and anhydrous THF (20 mL) was cooled to −78° C., evacuated and refilled with nitrogen for 10 cycles. To this clear solution was slowly added n-butyllithium (9.5 mL, 23.7 mmol) and stirred for 20 nm. Then a mixture of 1H-indole-6-carboxylic acid methoxy-methyl-amide (2.20 g, 10.8 mmol) in anhydrous THF (25 mL) was added and stirred for 1 hour at −78° C. The mixture was quenched with isopropanol (4.9 mL, 65 mmol) and water (15 mL). The mixture was extracted with EtOAc (3×50 mL). The combined organic phases were washed with water (2×50 mL), dried over MgSO4 and concentrated to give an oil, which was purified by flash column chromatography (EtOAc, Hexane) to give (3-ethoxy-4-methoxy-phenyl)-(1H-indol-6-yl)-methanone as an oil (2.30 g). The product was used in the next step without further purification.",4-bromo-2-ethoxy-1-methoxy-benzene | THF | nitrogen | n-butyllithium | 1H-indole-6-carboxylic acid methoxy-methyl-amide | THF | isopropanol | water | EtOAc | water | MgSO4 | EtOAc | Hexane | (3-ethoxy-4-methoxy-phenyl)-(1H-indol-6-yl)-methanone
US06211199B1,"Combine 1-benzyl-3-(phenylmethyl)-3-(2-methanesulfonyloxyethyl)-2-oxopyrrolidine (0.99 g, 2.57 mmol), (1-(4-fluorobenzyl)-1H-benzimidazol-2-yl)(piperidin-4-yl)amine (0.80 g, 2.57 mmol), and N,N-diisopropylethylamine (0.73 g, 5.65 mmol) in acetonitrile (37 mL). Heat to reflux. After 12 hours, cool and partition the reaction mixture between dichloromethane and water. Separate the layers and extract the organic layer with brine. Dry the organic layer over Na2SO4, filter, and concentrate in vacuo to obtain a residue. Chromatograph the residue on a short column of silica gel eluting with 2% triethylamine/10% methanol/ethyl acetate to give a residue. Partition the residue between dichloromethane and brine. Dry the organic layer over Na2SO4, filter, and concentrate in vacuo to give the title compound: Rf=0.22 (silica gel, 2% triethylamine/10% methanol/ethyl acetate).","1-benzyl-3-(phenylmethyl)-3-(2-methanesulfonyloxyethyl)-2-oxopyrrolidine | (1-(4-fluorobenzyl)-1H-benzimidazol-2-yl)(piperidin-4-yl)amine | N,N-diisopropylethylamine | acetonitrile | dichloromethane | water | brine | Na2SO4 | silica gel | triethylamine | dichloromethane | brine | Na2SO4 | title compound"
US08476294B2,"The title compound was synthesized in a similar manner as described for Example 1.1 using 8-bromo-1-(1,3-dimethyl-1H-pyrazol-4-yl)-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one (Intermediate A, 50 mg, 0.132 mmol) and 2-(2-benzyloxy-ethoxy)-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine (Stage 19.1.1, 65 mg, 0.184 mmol) to give the title compound as a white solid. (HPLC: tR 3.12 min (Method A); M+H=521 MS-ES; 1H-NMR (d6-DMSO, 400 MHz) 8.95 (s, 1H), 8.33-8.24 (m, 1H), 8.16-8.05 (m, 2H), 7.93-7.86 (m, 1H), 7.81-7.75 (m, 1H), 7.51-7.45 (m, 1H), 7.40-7.22 (m, 5H), 7.01-6.93 (m, 1H), 4.55 (s, 2H), 4.47 (t, 2H), 3.92 (s, 3H), 3.78 (t, 2H), 3.57 (s, 3H), 1.97 (s, 3H))","title compound | 8-bromo-1-(1,3-dimethyl-1H-pyrazol-4-yl)-3-methyl-1,3-dihydro-imidazo[4,5-c]quinolin-2-one | Intermediate A | 2-(2-benzyloxy-ethoxy)-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridine | title compound"
US20160214927A1,"Indian Publication No. 148/MUM/2011 discloses a process for the preparation of nepafenac in which 2-aminobenzophenone (II) is treated with 2-(methylthio)acetamide (III) in the presence of N-chlorophthalimide to afford 2-(2-amino-3-benzoylphenyl)-2-(methylthio)acetamide (IV), which is subsequently reduced in the presence of Raney nickel under hydrogen pressure to afford nepafenac.",nepafenac | 2-aminobenzophenone | 2-(methylthio)acetamide | N-chlorophthalimide | 2-(2-amino-3-benzoylphenyl)-2-(methylthio)acetamide
US08247401B2,"To a solution of methyl 3-(5-methylpyridin-2-yl)-5-{1-[(trimethylsilyl)methyl]-1H-1,2,3-triazol-5-yl}benzoate (122 mg, 0.321 mmol) in THF (5 mL) was added 2 M tetrabutylammonium fluoride in THF (1.60 mL, 3.20 mmol). After 16 h, the mixture was distributed between 100 ml of dichloromethane and 100 ml of 1 M ammonium chloride solution. The organic layer was washed with 50 mL of brine and concentrated to give title compound (85 mg). MS 309.1 (M+1).","methyl 3-(5-methylpyridin-2-yl)-5-{1-[(trimethylsilyl)methyl]-1H-1,2,3-triazol-5-yl}benzoate | THF | tetrabutylammonium fluoride | THF | dichloromethane | ammonium chloride | brine | title compound"
US08404856B2,"Compound 4-1 (400 mg; 0.694 mmol) was dissolved in 6 mL THF/MeOH (1:1) and the system purged with nitrogen (3×). 10% Pd/C (739 mg; 0.694 mmol) was then added to the reaction mixture which was then purged (3×) with nitrogen and then with hydrogen (3×). The purged reaction mixture then remained under atmospheric pressure of hydrogen for 4 hours at room temperature. The reaction mixture was then filtered through celite and concentrated. The crude product was then purified by flash chromatography (40-100% EtOAc in hexane) to give the title compound. MS M+1: 577.6. 1H NMR (CDCl3): 2.12 (t, 2H), 3.32 (t, 2H), 3.76 (s, 3H), 3.90 (s, 3H), 5.53 (s, 2H), 6.30 (s, 1H), 6.65 (d, 1H), 6.68 (d, 2H), 7.08 (m, 1H), 7.12 (m, 1H), 7.20 (d, 2H), 7.42 (m, 1H), 7.94 (t, 1H).",Compound 4-1 | THF/MeOH | nitrogen | Pd/C | nitrogen | hydrogen | crude product | EtOAc | hexane | title compound
US20120184542A1,"To a solution of tert-butyl 2-cyclohexyl-2-hydroxyethylcarbamate (6.11 g, 25.1 mmol), triphenylphosphine (7.57 g, 28.9 mmol) (Aldrich) and phthalimide (3.69 g, 25.1 mmol) (Aldrich) in THF (100 mL) was added diisopropylazo-dicarboxylate (5.69 mL, 28.9 mmol) (Aldrich) dropwise at room temperature with magnetic stirring. After 18 hours, mixture was concentrated and the residue was purified by flash chromatography eluting with 2-5% ethyl acetate in dichloromethane to give tert-butyl 2-cyclohexyl-2-(1,3-dioxoisoindolin-2-yl)ethylcarbamate. (Yield 7.37 g, 78.8%).","tert-butyl 2-cyclohexyl-2-hydroxyethylcarbamate | triphenylphosphine | phthalimide | THF | diisopropylazo-dicarboxylate | ethyl acetate | dichloromethane | tert-butyl 2-cyclohexyl-2-(1,3-dioxoisoindolin-2-yl)ethylcarbamate"
US09102676B2,"E1 (5.0 g 20.39 mmol) was dissolved in THF (45 mL) and cooled to −78° C. LHMDS (1 M in hexane/ethylbenzene) (40.8 mL, 40.8 mmol) was added in 30 minutes and the solution was stirred for 35 min at −78° C. (2-(Chloromethoxy)ethyl)trimethylsilane (10.02 mL, 56.5 mmol) was added and the reaction mixture was allowed to warm to room temperature overnight. The reaction mixture was quenched with saturated NH4Cl and extracted twice with EtOAc. The organic layer was washed with brine, dried over MgSO4, filtered and concentrated in vacuo. The residue was purified by flash column chromatography (heptane:EtOAc=100:0 to 70:30) yielding the title compound (6.09 g, 80%). 1H NMR (400 MHz, CDCl3, 300K): δ 0.00 (3H, s), 0.92 (2H, t, J=7.5 Hz), 1.47 (9H, s), 3.02 (2H, d, J=13.3 Hz), 3.55 (4H, m), 3.78 (3H, s), 3.83 (3H, m), 4.34 (1H, d, J=13.3 Hz). MS (ES) C17H33NO6Si requires: 375. found: 398.2 [M+Na]+.",E1 | THF | LHMDS | (2-(Chloromethoxy)ethyl)trimethylsilane | NH4Cl | EtOAc | brine | MgSO4 | heptane | EtOAc | title compound
US04304770,"2-(3-Chloro-4-hydroxyphenyl)glyoxylic acid (2.0 g.) and O-(1-t-butoxycarbonylethyl)hydroxylamine (3.2 g.) were reacted according to a similar manner to that of Preparation (5-7) to give 2-(1-t-butoxycarbonylethoxyimino)-2-(3-chloro-4-hydroxyphenyl)acetic acid (syn isomer) (3.3 g.), mp 148° to 151° C.",2-(3-Chloro-4-hydroxyphenyl)glyoxylic acid | O-(1-t-butoxycarbonylethyl)hydroxylamine | (5-7) | 2-(1-t-butoxycarbonylethoxyimino)-2-(3-chloro-4-hydroxyphenyl)acetic acid
US05194440,"A solution of the product from Step 1 (916 mg) in anhydrous dichloromethane (15 ml) and trifluoroacetic acid (4.5 ml) was stirred at room temperature under a nitrogen atmosphere for 1 hour. Solvents were removed under vacuum and the residue was azeotroped with toluene-methanol. Flash chromatography of the crude product (silica gel, dichloromethane-methanol-ammonia, 90:10:1) gave 372 mg (59%) of the title compound as a colourless thick oil which solidified on standing; δH (250 MHz, CDCl3) 8.16 (1H, br s, indole N--H), 7.45 (1H, s, Ar--H), 7.28 (1H, d, J=8.3 Hz, Ar--H), 7.05 (1H, dd, J=8.3 and 1.5 Hz, Ar--H), 7.02 (1H, d, J=1.8 Hz, Ar--H), 3.35 (2H, dd, J=9.8 and 7.1 Hz, --CH2N--), 3.26 (4H, s, --NCH2CH2N-- ), 3.08--2.99 (4H, m, --CH2 --), 2.88 (2H, t, J=6.2 Hz, Ar--CH2CH2NH2), 2.75 (3H, s, --NMe); m/z (CI) 323 (M+ +1). (Found: m/z 323.1543. C15H23N4O2S requires: m/z 323.1542).",product | dichloromethane | trifluoroacetic acid | nitrogen | toluene-methanol | crude product | title compound
US20160264579A1,"4-(4-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)aniline (200 mg) produced in accordance with Example 7→Example 2 using 4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidine and cyclopentanol, as well as the compound (140 mg) produced in Example 50 were used and subjected to the same procedure as in Example 49→Example 3 to obtain the title compound (290 mg) having the following physical property values.","4-(4-chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)aniline | 4-chloro-5-iodo-7H-pyrrolo[2,3-d]pyrimidine | cyclopentanol | compound | title compound"
US08541418B2,"Three mL of TFA was added to a solution of (R)-tert-butyl 4-(8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)pyridin-3-ylcarbamate (Example 92, 760 mg) in 3 mL of DCM. The mixture was stirred for 4 h at rt, and the solvent was removed under reduced pressure. Aqueous Na2CO3 was added and extracted with EtOAc. The organic layer was dried with Na2SO4, concentrated and the residue was purified by silica column to give the title compound. LCMS (0.05% TFA): 353.0 m/z (M+H)+; 1H-NMR (CDCl3, 500 MHz): δ: 8.17 (s, 1H), 8.08 (d, 1H, J=5 Hz), 7.99 (d, 1H, J=5 Hz), 7.94 (s, 1H), 6.23 (s, 2H), 4.48 (m, 1H), 4.32 (m, 1H), 3.39 (s, 3H), 2.0-1.69 (m, 10H), 0.88 (t, 3H, J=7.5 Hz).","TFA | (R)-tert-butyl 4-(8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)pyridin-3-ylcarbamate | DCM | Na2CO3 | EtOAc | Na2SO4 | silica | title compound"
US20080076766A1,"A solution of 0.025 ml diisopropylazodicarboxylate in 1 ml of tetrahydrofuran is added dropwise to a solution of 0.045 g 4-{4-[1-(3-fluor-phenyl)-pyrrolidin-3-yloxy]-phenyl}-3-hydroxy-5-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo[1,4]-oxazin-6-ylmethoxy]-piperidine-1-carboxylic acid benzyl ester (example 1a), 0.015 g benzoic acid and 0.032 g triphenylphosphine in 1 ml of tetrahydrofuran The reaction solution is stirred for 3 hours at room temperature and is then concentrated under reduced pressure. The residue is purified through a short pad of SiO2. The crude material is then dissolved in 2.5 ml of methanol/tetrahydrofuran 4:1. Potassium carbonate (0.034 g) is added to the solution and the mixture is stirred for 16 hours at room temperature. The reaction mixture is quenched with water and extracted with tert-butyl methyl ether (2×). The combined organics are washed with brine, dried (sodium sulphate) and concentrated under reduced pressure. The title compound is obtained as a colorless glass and can be used without further purification. Rf=0.51 (EtOAc-heptane 2:1); Rt=5.59.","diisopropylazodicarboxylate | tetrahydrofuran | 4-{4-[1-(3-fluor-phenyl)-pyrrolidin-3-yloxy]-phenyl}-3-hydroxy-5-[4-(3-methoxy-propyl)-3,4-dihydro-2H-benzo[1,4]-oxazin-6-ylmethoxy]-piperidine-1-carboxylic acid benzyl ester | benzoic acid | triphenylphosphine | tetrahydrofuran | SiO2 | crude material | methanol/tetrahydrofuran | Potassium carbonate | water | tert-butyl methyl ether | brine | sodium sulphate | title compound"
US20160008357A1,"To a solution of compound 26 (20 mg, 0.056 mmol) in THF (3 mL), LAH (5.0 mg, 0.14 mmol) was added at −30° C. and stirred for 1 h. The reaction mixture was quenched with saturated ammonium chloride solution at −30° C. The reaction mixture was slowly warmed to rt and filtered through celite bed, washed with ethyl acetate. The organic layer was washed with brine, dried over anhy. Na2SO4 and concentrated under reduced pressure to obtain the crude product gave (2-(3,5-diphenylpyridazin-4-yl) oxazol-4-yl) methanol (16 mg, 88%) as an yellow solid.","compound 26 | THF | LAH | ammonium chloride | ethyl acetate | brine | Na2SO4 | crude product | (2-(3,5-diphenylpyridazin-4-yl) oxazol-4-yl) methanol"
US08486979B2,"The title compound was prepared according to the procedure of Example 8 using N′-hydroxynicotinimidamide (Aldrich) and 3-fluoro-4-hydroxybenzoic acid (Aldrich). 1H NMR (300 MHz, CD3OD) δ 7.09 (t, J=8.7 Hz, 1 H), 7.63 (ddd, J=7.9, 5.2, 0.8 Hz, 1 H), 7.86-7.93 (m, 2 H), 8.53 (dt, J=7.9, 2.0 Hz, 1 H), 8.72 (dd, J=4.8, 1.6 Hz, 1 H), 9.27 (dd, J=2.4, 0.8 Hz, 1 H) ppm; MS (DCI/NH3) m/z 258 (M+H)+.",title compound | N′-hydroxynicotinimidamide | 3-fluoro-4-hydroxybenzoic acid | NH3
US20110212968A1,"Under inert gas a solution of 3-bromo-pyridine-2-carboxylic acid (4.95 mmol) in MeOH (8.0 mL) is treated dropwise with conc. sulfuric acid (0.50 mL) and heated subsequently to reflux for 150 min. The mixture is cooled to 0° C. and neutralized by addition of DIPEA. After removal of the volatiles EtOAc (30 mL) and water (10 mL) are added and the layers are separated. The organic layer is washed twice with sat. NaHCO3 solution (2×10 mL) and once with water (10 mL), dried over MgSO4 and concentrated in vacuo to give the crude product which is used without further purification. LC-MS (B): tR=0.69 min; [M+H]+=216.0. 1H-NMR (CDCl3): δ=4.04 (s, 3H), 7.32 (m, 1H), 8.03 (d, J=8.0 Hz, 1H), 8.63 (m, 1H).",3-bromo-pyridine-2-carboxylic acid | MeOH | sulfuric acid | DIPEA | EtOAc | water | NaHCO3 | water | MgSO4 | crude product
US20040259915A1,"To a clean dry 200 ml flask purged with nitrogen was added diisopropylamine (2.7 ml, 19.5 mmol, 3 eq), dry THF (50 mL) and 3-(2,4-Bis-methoxymethoxy-phenyl)-7-methoxymethoxy-4-methyl-chromen-2-one (8.1 mL, 16.25 mmol, 2.5 eq.) at −78° C. After 30 minutes, to this solution was added drop-wise, a solution of 3-(2,4-bis-methoxymethoxy-phenyl)-7-methoxymethoxy-4-methyl-chromen-2-one (2.7 g, 6.5 mmol, 1 eq.) in dry THF (13 mL). The solution was warmed to −10C and stirred at this temperature for 30 minutes. Phenyl formate (3.6 ml, 33 mmol, 5 eq) was then added slowly into the reaction mixture. The reaction mixture was then stirred for 30 mins, quenched with saturated aqueous NH4Cl, extracted with ethyl acetate and then concentrated to yield th title product as a crude solid which was purified by flash chromatography eluting with 30% ethyl acetate in hexane to yield the title product as a solid.","nitrogen | diisopropylamine | THF | 3-(2,4-Bis-methoxymethoxy-phenyl)-7-methoxymethoxy-4-methyl-chromen-2-one | 3-(2,4-bis-methoxymethoxy-phenyl)-7-methoxymethoxy-4-methyl-chromen-2-one | THF | Phenyl formate | NH4Cl | ethyl acetate | title product"
US07211577B2,"Following the procedure of Example 1(10), 2-benzyl-6-(4-fluoro-3-methylphenyl)-4-methanesulfonyloxymethyl-2H-pyridazin-3-one and tert-butyl 1-piperazinecarboxylate were reacted to yield the title compound as a yellow oil (yield: 91.8%).",2-benzyl-6-(4-fluoro-3-methylphenyl)-4-methanesulfonyloxymethyl-2H-pyridazin-3-one | tert-butyl 1-piperazinecarboxylate | title compound
US20080114164A1,"A suspension of sodium hydride (60% in mineral oil,13.6 g, 368 mmol) in N,N-dimethylformamide (160 ml) was cooled to −10° C. or below under a nitrogen atmosphere. Ethyl isocyanoacetate (36.2 g, 320 mmol) was gradually added dropwise to the cooled suspension, and the mixture was stirred at −3 to 5° C. for 2 hr. This solution was cooled to −20° C. or below and was added dropwise to a solution of 2,5-dibromothiazole (38.8 g, 160 mmol) in N,N-dimethylformamide over a period of about 20 min, and the mixture was stirred at −5 to −20° C. for 2 hr. Water (8 ml) was added thereto to stop the reaction, and the reaction solution was added to 15 wt % brine (960 ml) under ice cooling. Subsequently, the mixture was adjusted to pH 6 to 7 by the addition of 1 M hydrochloric acid. Subsequently, common salt (102 g) was added thereto at the same temperature, and the mixture was stirred overnight. The resultant precipitate was collected by filtration, was washed with water (136 ml), and was dried under the reduced pressure to give ethyl 2-bromoimidazo[5,1-b]thiazole-7-carboxylate (40.4 g, yield 91.9%).","sodium hydride | N,N-dimethylformamide | nitrogen | Ethyl isocyanoacetate | 2,5-dibromothiazole | N,N-dimethylformamide | Water | brine | ice | hydrochloric acid | salt | resultant precipitate | water | ethyl 2-bromoimidazo[5,1-b]thiazole-7-carboxylate"
US08168633B2,"Prepared according to the method used in the preparation of 5-(5-chloro-7-morpholin-4-ylthiazolo[4,5-d]pyrimidin-2-ylmethyl)-hexahydro-pyrrolo[3,4-c]pyrrole-2-carboxylic acid tert-butyl ester using 1-cyclopropylmethylpiperazine in place of hexahydro-pyrrolo[3,4-c]pyrrole-2-carboxylic acid tert-butyl ester. The title compound was obtained as a yellow solid (170 mg, 58%).","5-(5-chloro-7-morpholin-4-ylthiazolo[4,5-d]pyrimidin-2-ylmethyl)-hexahydro-pyrrolo[3,4-c]pyrrole-2-carboxylic acid tert-butyl ester | 1-cyclopropylmethylpiperazine | title compound | solid"
US07582644B2,"The subtitle compound was prepared according to the procedure of Example 1 step i) treating 4-amino-6-hydroxy-2-mercaptopyrimidine monohydrate (2.0 g) with 3,4-difluorobenzyl bromide (2.66 g) to afford the subtitle compound as a white solid. Yield: 3.35 g.","subtitle compound | 4-amino-6-hydroxy-2-mercaptopyrimidine monohydrate | 3,4-difluorobenzyl bromide | subtitle compound"
US06894061B2,"A stirred suspension of 3-methoxy-N-[1-(2′,4,4′-trifluoro-1,1′-biphenyl-2-yl)ethyl]benzenesulfonamide (0.88 g, 2.1 mmol) and potassium carbonate (0.58 g, 4.2 mmol) in N,N-dimethylformamide (5 mL) was heated for twelve hours at 100° C. The reaction mixture was cooled and poured into distilled water. After stirring overnight at room temperature, a precipitate was filtered and dried under high vacuum. The title compound (0.81 g, 2.0 mmol, 96%) was obtained as a colorless, fine, crystalline powder, m.p. 147-149° C.;","3-methoxy-N-[1-(2′,4,4′-trifluoro-1,1′-biphenyl-2-yl)ethyl]benzenesulfonamide | potassium carbonate | N,N-dimethylformamide | water | title compound"
US08207172B2,"To ethanol (60 mL) were sequentially added 4-chloro-5,8-dihydro-6H-spiro[1-benzothieno[2,3-d]pyrimidine-7,2′-[1,3]dioxolane] (5.70 g, 20.2 mmol), 3-Chloro-4-(pyridin-2-ylmethoxyl)-phenylamine (4.78 g, 20.37 mmol), and HCl in ethanol (1N, 4 mL). The suspension was stirred with heating to 80° C., upon which time the contents turn brown and homogeneous. After 12 h, the dark orange-yellow heterogeneous mixture was removed from heating, and allowed to cool to rt. The contents were concentrated down to about 30 mL in volume and the precipitate was collected by filtration as a light-brown solid (10.1 g, 92%). 1H-NMR (DMSO-d6) δ 8.71 (d, 1H), 8.40 (s, 1H), 8.33 (s, 1H), 8.10 (td, 1H), 7.80 (d, 1H), 7.75 (d, 1H), 7.56 (m, 2H), 7.25 (d, 1H), 5.48 (br, 1H), 5.38 (s, 2H), 3.99 (s, 4H), 3.28 (t, 2H), 3.03 (s, 2H), 1.97 (t, 2H); LCMS RT=2.73 min; [M+H]+=481.1.","ethanol | 4-chloro-5,8-dihydro-6H-spiro[1-benzothieno[2,3-d]pyrimidine-7,2′-[1,3]dioxolane] | 3-Chloro-4-(pyridin-2-ylmethoxyl)-phenylamine | HCl | ethanol | solid"
US20050014727A1,"A suspension of 3-(3-methoxy-4-nitro-phenyl)-3-(3,4,5-trimethoxy-phenyl)-acrylonitrile (0.9 g, 2.4 mmol) and tin chloride dihydrate (4.0 g, 17.7 mmol) in ethanol (25 mL) was heated at 70° C. for 1 h. The mixture was cooled and poured into ice (200 mL). The pH was made strongly alkaline by the addition of ION NaOH. The mixture was extracted with EtOAc (5×50 mL) and the combined organic extracts were washed with water (40 mL), brine (40 mL), and dried (MgSO4). Solvent was removed and the residue was purified by flash chromatography (silica gel, Hexane: EtOAc 1:1) to afford mixture isomers of 3-(4-amino-3-methoxy-phenyl)-3-(3,4,5-trimethoxy-phenyl)-acrylonitrile (0.4 g, 42%) as a yellow solid: mp 123-125° C.; 1H NMR (CDCl3) δ 7.05-6.53 (m, 5H), 5.56(5.43) (s, 1H), 4.12 (s, 2H), 3.91-3.81 (m, 12H); 13C NMR (CDCl3) δ 163.19, 163.09, 152.99, 152.93, 146.63, 139.82, 138.74, 135.43, 132.66, 128.33, 126.35, 124.12, 118.96, 113.76, 113.74, 111.99, 110.22, 107.35, 106.42, 91.14, 90.52, 60.94, 56.28, 56.25, 55.74, 55.59; Anal Calcd for C19H20N2O4: C, 67.05; H, 5.92; N, 8.23. Found: c, 66.92; H, 5.76; N, 8.10.","3-(3-methoxy-4-nitro-phenyl)-3-(3,4,5-trimethoxy-phenyl)-acrylonitrile | tin chloride dihydrate | ethanol | ice | NaOH | EtOAc | water | brine | MgSO4 | silica gel | 3-(4-amino-3-methoxy-phenyl)-3-(3,4,5-trimethoxy-phenyl)-acrylonitrile"
US09409952B2,"A solution of (S)-2-amino-3-mercaptopropanoic acid hydrochloride hydrate (1.00 g, 5.69 mmol) in methanol (5.1 mL) was mixed with a solution of the prepared S-tert-butyl methanesulfonothioate (Compound SP684, 1.05 g, 6.26 mmol) in tetrahydrofuran (2.0 mL) and triethylamine (2.38 mL, 17.1 mmol) with stirring at 0° C., and the reaction mixture was stirred at room temperature for 3 hours. The reaction mixture was purified by reverse-phase silica gel column chromatography (0.1% aqueous formic acid solution/0.1% formic acid-acetonitrile solution) to afford (S)-2-amino-3-(tert-butyldisulfanyl)propanoic acid (H-D-Cys(StBu)-OH) (Compound SP641) (620 mg, 2.96 mmol, 52%).",(S)-2-amino-3-mercaptopropanoic acid hydrochloride hydrate | methanol | S-tert-butyl methanesulfonothioate | tetrahydrofuran | triethylamine | silica gel | formic acid | formic acid-acetonitrile | (S)-2-amino-3-(tert-butyldisulfanyl)propanoic acid
US20080292588A1,"To a solution of 3-(7-amino-1-methyl-1-oxo-1λ6-benzo[1,2,4]thiadiazin-3-yl)-5-tert-butyl-1-(3-chloro-4-fluoro-benzyl)-4-hydroxy-1,5-dihydro-pyrrol-2-one (31) (0.046 g, 0.093 mmol) in acetone (1.5 mL) added pyridine (0.153 mL, 1.87 mmol) followed by dropwise addition of methane sulfonylchloride (0.108 mL, 1.39 mmol). The reaction mixture was stirred at room temperature for 2.5 h, then diluted with ethyl acetate (50 mL), washed with 0.5 N HCl (50 mL) and brine (50 mL) via extraction. The separated organic layer was dried over MgSO4 and concentrated to dryness under reduced pressure. The crude product thus obtained was further purified by prep-TLC plate coated with a thin layer of silica gel to afford N-{3-[5-tert-butyl-1-(3-chloro-4-fluoro-benzyl)-4-hydroxy-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-1-methyl-1-oxo-1λ6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide (32) (3.9 mg, 7.4% yield) as a solid. 1H NMR (400 MHz, CDCl3) δ: 1.08 (s, 9H), 3.08 (s, 3H), 3.23-3.33 (m, 1H), 3.59 (s, 3H), 4.30 (d, 1H, J=15.6 Hz), 5.17 (d, 1H, J=16.3 Hz), 7.05-7.09 (m, 2H), 7.22-7.24 (m, 2H), 7.57-7.67 (m, 1H), 7.75-7.75 (m, 1H). LC-MS (ESI+): m/e 569.2 [M+1]+ (exact ms: 568.1).","3-(7-amino-1-methyl-1-oxo-1λ6-benzo[1,2,4]thiadiazin-3-yl)-5-tert-butyl-1-(3-chloro-4-fluoro-benzyl)-4-hydroxy-1,5-dihydro-pyrrol-2-one | acetone | pyridine | methane sulfonylchloride | ethyl acetate | HCl | brine | MgSO4 | crude product | N-{3-[5-tert-butyl-1-(3-chloro-4-fluoro-benzyl)-4-hydroxy-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-1-methyl-1-oxo-1λ6-benzo[1,2,4]thiadiazin-7-yl}-methanesulfonamide"
US04853383,"A solution of 3 (195 g, 0.76 mol), benzoic acid (3.0 g), benzaldehyde (270 ml), C6H6 (180 ml) was heated to reflux while collecting the H2O in a Dean-Stark trap. After 21/2 hours, 13 ml of H2O was collected and the solution cooled, washed with saturated Na2CO3. The aqueous layer was washed with CHCl3 (2X) and the combined extracts dried, filtered and concentrated to dryness to yield 232 g of 5 which contains 26 mol % benzaldehyde. This corresponds to 209 g of 5; 'H NMR (CDCl3) δ 2.6 (6H, m), 3.4 (2H, m), 3.75 (7H, d, m), 4.3 (1H, m), 4.8 (1H, d), 6.7 (3H, m), 7.4 (5H, bs). ##STR150##",3 | benzoic acid | benzaldehyde | C6H6 | H2O | H2O | Na2CO3 | CHCl3 | 5
US08252931B2,"To a 1 L round bottom flask containing 250 mL of 9:1 THF/DMPU at −78° C. are added under nitrogen 11 mL (78.6 mmol) anhydrous DIEA followed by rapid addition of 32 mL of 2.5 M n-BuLi in hexanes. After 10 min at −78° C. a solution of 15.4 g (74 mmol) of p-nitrophenylacetic acid, ethyl ester in 100 mL of 9:1 THF/DMPU is added dropwise over 30 min. A deep purple solution results, and the reaction mixture is stirred at −78° C. for 30 min and then cyclopentyl methyl iodide (17.6 g, 78 mmol) in 50 mL of 9:1 THF/DMPU is added. The reaction is stirred while warming slowly to RT overnight. The mixture is poured into 1 L of 1 N HCl and extracted twice with MTBE. The combined MTBE extracts are washed with brine, dried over anhydrous magnesium sulfate, filtered and reduced to an orange oil. Flash chromatography over silica eluting with 4:1 hexane/MTBE affords 3-cyclopentyl-2-(4-nitro-phenyl)-propionic acid ethyl ester as an orange oil: 1H NMR (400 MHz, CDCl3) δ 1.0-1.1 (m, 2H), 1.2 (t, 3H, J=7.2), 1.4-1.8 (m, 5H), 1.8-1.9 (m, 2H), 2.1-2.25 (m, 2H), 3.74 (t, 1H, J=7.8), 4.1 (m, 2H), 7.51 (d, 2H, J=8.8), 8.19 (d, 2H, J=8.8); LC/MS 290 (M−1).","THF/DMPU | nitrogen | n-BuLi | hexanes | p-nitrophenylacetic acid, ethyl ester | THF/DMPU | cyclopentyl methyl iodide | THF/DMPU | HCl | MTBE | MTBE | brine | magnesium sulfate | silica | hexane/MTBE | 3-cyclopentyl-2-(4-nitro-phenyl)-propionic acid ethyl ester"
US20140134193A1,"Synthesis of (2S,3Z)-5-{[(2R,3R,5S,6S)-6-{(2E,4E)-5-[(3S,5S,7S)-7-(2-{(2E)-2-[1-(4-{4-[(2,5-dioxopyrrolidin-1-yl)oxy]-4-oxobutoxy}phenyl)ethylidene]hydrazinyl}-2-oxoethyl)-1,6-dioxaspiro[2.5]oct-5-yl]-3-methylpenta-2,4-dien-1-yl}-2,5-dimethyltetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate (#B19). To a solution of #B18 (25 mg, 0.034 mmol, 1 eq.) dissolved in tetrahydrofuran (0.7 mL, 0.049 M) was added DCC (15.5 mg, 0.075 mmol, 2.2 eq.) followed by N-Hydroxy succinimide (8.60 mg, 0.075 mmol, 2.2 eq.). The reaction was stirred for 4 hours. Solvents were removed in vacuo and the residue was purified by reverse phase chromatography (Method A) to afford #B19 as a white solid. Yield: 13 mg, 0.015 mmol, 46%. LCMS (Protocol D); m/z 835.8 [M+H]+, retention time=0.92 minutes.","(2S,3Z)-5-{[(2R,3R,5S,6S)-6-{(2E,4E)-5-[(3S,5S,7S)-7-(2-{(2E)-2-[1-(4-{4-[(2,5-dioxopyrrolidin-1-yl)oxy]-4-oxobutoxy}phenyl)ethylidene]hydrazinyl}-2-oxoethyl)-1,6-dioxaspiro[2.5]oct-5-yl]-3-methylpenta-2,4-dien-1-yl}-2,5-dimethyltetrahydro-2H-pyran-3-yl]amino}-5-oxopent-3-en-2-yl acetate | tetrahydrofuran | DCC | N-Hydroxy succinimide"
US08148391B2,"Title compound was prepared from 8-Amino-1,3,4,5-tetrahydro-benzo[b]azepin-2-one and (2,5-Dichloro-pyrimidin-4-yl)-(2-fluoro-6-methanesulfonyl-phenyl)-amine in an analogous manner to Example 1221d. Product isolated as an off-white solid (52 mg, 41%). MP=242-245, LCMS 478.05 (M+H), HPLC purity 93%, 1H-NMR (DMSO-d6, 400 MHz) δ 9.50 (s, 1H), 9.19 (s, 1H), 8.89 (s, 1H), 8.20 (s, 1H), 7.85 (d, J=8.0 Hz, 1H), 7.75-7.72 (m, 1H), 7.67-7.64 (m, 1H), 7.02 (d, J=8.0 Hz, 1H), 6.93 (s, 1H), 6.84 (d, J=8.0 Hz, 1H), 3.21 (s, 3H), 2.55-2.51 (m, 2H), 2.07-2.04 (m, 4H).","Title compound | 8-Amino-1,3,4,5-tetrahydro-benzo[b]azepin-2-one | (2,5-Dichloro-pyrimidin-4-yl)-(2-fluoro-6-methanesulfonyl-phenyl)-amine | solid"
US09034887B2,"Concentrated sulphuric acid (1 mL) was added to a solution of 2-amino-4-methyl-benzoic acid (1.0 g, 6.62 mmol) in dry methanol (10 mL) at 0° C., and then heated at reflux for 16 hr. The mixture was cooled to room temperature and concentrated in vacuo. The crude compound was diluted with water (25 mL) and basified with sodium bicarbonate (10 mL). The aqueous layer was extracted with ethyl acetate (2×50 mL) and the combined organic layers were washed with water (50 mL), brine (50 mL) and dried over sodium sulfate. The organic layer was concentrated under reduced pressure affording 2-amino-4-methyl-benzoic acid methyl ester (900 mg, 82%) as yellow liquid.",sulphuric acid | 2-amino-4-methyl-benzoic acid | methanol | crude compound | water | ethyl acetate | water | brine | sodium sulfate | 2-amino-4-methyl-benzoic acid methyl ester
US20150045394A1,"DIPEA (200 μl, 0.567 mmol) was added to a suspension of 2-hydroxy-4-phenyl-3-(2-(2-phenylthiazol-4-yl)nicotinamido)butanoic acid (250 mg, 0.544 mmol) und O-methylhydroxylamine hydrochloride (90 mg, 1.078 mmol) in dichloromethane (50 ml) at 5° C. After about 5 min 2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (HATU) (665 mg, 1.748 mmol) was added, the pH adjusted to 8 via addition of further DIPEA, and the mixture then stirred for 1 h at 5° C. and then overnight at room temperature. Then dichloromethane (50 ml) was added, washed 2× with 10 ml of water and brine, dried, filtered and concentrated to give 430 mg of the crude product which was purified by chromatography on silica gel (dichloromethane+11-12% methanol. Concentration of the combined fractions and drying afforded 224 mg of a white amorphous solid;","DIPEA | 2-hydroxy-4-phenyl-3-(2-(2-phenylthiazol-4-yl)nicotinamido)butanoic acid | dichloromethane | 2-(1H-7-azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate | DIPEA | dichloromethane | water | brine | crude product | silica gel | dichloromethane | white amorphous solid"
US20090099177A1,"1M TBAF in THF (1.03 mL, 1.03 mmol) added dropwise to a solution of 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarbaldehyde (266.8 mg, 0.68 mmol) and TMSCF3 [trimethyl(trifluoromethyl)silane, 151 μL, 1.02 mmol] in THF at 0° C. Stirred for 2 days at room temperature then left to stand for 1 day. Diluted with Et2O and washed with water, dried (Na2SO4), filtered and evaporated. Purified on 10 g SPE silica cartridge with hexane+EtOAc (5-10%) as eluent to give the title compound (148.8 mg, 47%).",TBAF | THF | 6-[(5-chloro-2-{[(4-chloro-2-fluorophenyl)methyl]oxy}phenyl)methyl]-2-pyridinecarbaldehyde | TMSCF3 | THF | Et2O | water | Na2SO4 | silica | title compound
US04399137,"6.7 g (35 millimoles) of 3-chloro-6-(2-methyl-imidazol-1-yl)-pyridazine are taken up in 30 ml of hydrazine hydrate and the mixture is heated for 5-10 hours at 100°-130° C. under nitrogen as a protective gas; the reaction mixture becomes homogeneous in the course of the first few hours. When the mixture has cooled, the crude product which has precipitated is filtered off. It is also possible to pour the reaction mixture into ice water and extract the mixture repeatedly with methylene chloride. Continuous extraction by means of a rotary perforator, using methylene chloride or chloroform as the extraction solvents, has also proved an advantageous method. Yet a further possibility is to distil off the hydrazine hydrate under reduced pressure.",3-chloro-6-(2-methyl-imidazol-1-yl)-pyridazine | hydrazine hydrate | nitrogen | crude product | ice water | methylene chloride | hydrazine hydrate
US07825114B2,"In analogy to GP 2, reaction of 7.2 g Intermediate 1.1 (20.4 mmol, 1 eq.), 2.5 mL dry pyridine (30.6 mmol, 1.5 eq.), 5.14 ml trifluoromethanesulfonic acid anhydride (30.6 mmol, 1.5 eq.) in 320 mL DCM yielded 4.2 g 2-pyridyl triflate (8.65 mmol, 43% yield).",Intermediate 1.1 | pyridine | trifluoromethanesulfonic acid anhydride | DCM | 2-pyridyl triflate
US08791102B2,"Proceeding as in Reference 5, but substituting 4-(p-tolyloxy)aniline and (S)-3-(benzyloxy)-2-(tert-butoxycarbonylamino)propanoic acid, gave (S)-2-amino-3-(benzyloxy)-N-(4-(p-tolyloxy)phenyl)propanamide (350 mg, 92%).",4-(p-tolyloxy)aniline | (S)-3-(benzyloxy)-2-(tert-butoxycarbonylamino)propanoic acid | (S)-2-amino-3-(benzyloxy)-N-(4-(p-tolyloxy)phenyl)propanamide
US20100075952A1,"The title compound was prepared under the same conditions as described in step of Example 32 with 3-methyl-4-oxo-5-(2-piperidin-1-yl-ethyl)-1,4,5,6,7,8-hexahydro-pyrrolo[3,2-c]azepine-2-carbaldehyde 32d obtained from step 4 of Example 32 and 5-fluoro-6-(4-fluoro-benzylamino)-1,3-dihydro-indol-2-one 3e obtained from step 4 of Example 3 as starting materials to obtain 2-[5-fluoro-6-(4-fluoro-benzylamino)-2-oxo-1,2-dihydro-indol-3-ylidenemethyl]-3-m ethyl-5-(2-piperidin-1-yl-ethyl)-5,6,7,8-tetrahydro-1H-pyrrolo[3,2-c]azepin-4-one 55 (77 mg, yield 90.8%) as a yellow solid.","title compound | 3-methyl-4-oxo-5-(2-piperidin-1-yl-ethyl)-1,4,5,6,7,8-hexahydro-pyrrolo[3,2-c]azepine-2-carbaldehyde | 5-fluoro-6-(4-fluoro-benzylamino)-1,3-dihydro-indol-2-one | 2-[5-fluoro-6-(4-fluoro-benzylamino)-2-oxo-1,2-dihydro-indol-3-ylidenemethyl]-3-m ethyl-5-(2-piperidin-1-yl-ethyl)-5,6,7,8-tetrahydro-1H-pyrrolo[3,2-c]azepin-4-one"
US20120184523A1,"Crude cyclopropane-1,1-dicarboxylic acid [3-fluoro-4-(6-hydroxy-7-methoxy-quinazolin-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide (333 mg, 0.66 mmol), PS-PPh3 resin, (loading=2.33 mmol/g, 797 mg, 1.86 mmol), 3-morpholin-4-yl-propan-1-ol (0.26 ml, 1.88 mmol), and DEAD (0.31 ml, 1.91 mmol) were combined in CH2Cl2 (10 ml) and stirred at room temperature for 1-2 hrs. The reaction mixture was filtered and the resin thoroughly washed with CH2Cl2. The filtrate was concentrated in vacuo and the resulting residue was dissolved in EtOAc and washed with H2O (4×) and sat'd NaCl (1×) and then extracted with 1N HCl (3×). The combined 1N HCl extractions were washed with EtOAc (2×). The acidic aqueous phase was then basified with 1N NaOH and extracted with EtOAc (3×). The combined EtOAc extractions were washed with H2O (1×), sat'd NaCl (1×), dried (Na2SO4), and concentrated in vacuo. The resulting residue was purified by preparative reverse phase HPLC (25 mM NH4OAc/acetonitrile) and the pure fractions were lyophilized to give cyclopropane-1,1-dicarboxylic acid {3-fluoro-4-[7-methoxy-6-(3-morpholin-4-yl-propoxy)-quinazolin-4-yloxy]-phenyl}-amide (4-fluoro-phenyl)-amide (42.6 mg, 10%). 1H NMR (400 MHz, DMSO-d6): δ 10.37 (br s, 1H), 10.05 (br s, 1H), 8.55 (s, 1H), 7.84 (m, 1H), 7.65 (m, 2H), 7.58 (s, 1H), 7.43 (m, 3H), 7.16 (t, 2H), 4.27 (m, 2H), 4.00 (s, 3H), 3.60 (m, 6H), 2.39 (m, 4H), 1.99 (m, 2H), 1.47 (m, 4H). LC/MS Calcd for [M+H]+ 634.2. Found 634.1.","cyclopropane-1,1-dicarboxylic acid [3-fluoro-4-(6-hydroxy-7-methoxy-quinazolin-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide | PPh3 | 3-morpholin-4-yl-propan-1-ol | DEAD | CH2Cl2 | CH2Cl2 | EtOAc | H2O | NaCl | HCl | HCl | EtOAc | EtOAc | EtOAc | H2O | NaCl | Na2SO4 | NH4OAc/acetonitrile | cyclopropane-1,1-dicarboxylic acid {3-fluoro-4-[7-methoxy-6-(3-morpholin-4-yl-propoxy)-quinazolin-4-yloxy]-phenyl}-amide (4-fluoro-phenyl)-amide"
US07399775B2,"Under stirring at −78° C., tert-butyl lithium (1.51M pentane solution: 4.6 ml) was added dropwise to a solution of 2,5-dichloropyridine (1.02 g, 6.89 mmol) in ether (20 ml). After stirring at −78° C. for 2 hours, pyridin-4-carbaldehyde (0.65 ml, 6.89 mmol) was added to the reaction mixture. The resulting mixture was stirred at −78° C. for 1 hour. Water was added to the reaction mixture and the temperature was raised to room temperature. The mixture was extracted with methylene chloride. The extract was dried over anhydrous sodium sulfate and filtered. The filtrate was then concentrated under reduced pressure. The residue thus obtained was subjected to chromatography on a silica gel column. A fraction obtained from the eluate with methanol:methylene chloride (1:50) was concentrated under reduced pressure. The solid thus obtained was washed with ether and collected by filtration, whereby the title compound (819 mg, 3.21 mmol, 47%) was obtained as a white powder.","tert-butyl lithium | 2,5-dichloropyridine | ether | pyridin-4-carbaldehyde | Water | methylene chloride | sodium sulfate | methanol:methylene chloride | ether | title compound"
US20160221945A1,"DIBAL-H (17 mL, 119.53 mmol, 1M in hexanes, 3.00 equiv) was added dropwise into a solution of methyl 4-(6-methylpyrimidin-4-yl)bicyclo[2.2.2]octane-1-carboxylate (1.5 g, 5.76 mmol, 1.00 equiv) in dichloromethane (150 mL) at −78° C. under nitrogen. The resulting solution was stirred for 3 h at −78° C. The reaction was then quenched by sodium hydroxide (1N). The solids were filtered out. The filtrate was dried over anhydrous sodium sulfate and concentrated under vacuum. This resulted in the title compound (1.1 g, 82%) as a white solid.",DIBAL-H | methyl 4-(6-methylpyrimidin-4-yl)bicyclo[2.2.2]octane-1-carboxylate | dichloromethane | nitrogen | sodium hydroxide | sodium sulfate | title compound
US04684652,"The procedure of Example 24 is followed using ethyl 2-phenylquinazoline-4-carboxylate (2 g), piperidin-4-ol (1.4 g), a 1.6M solution of butyllithium in hexane (18 ml) and tetrahydrofuran (30 ml) as the starting materials. After recrystallisation from a mixture of methanol and methylene chloride, 1-[(2-phenylquinazolin-4-yl)-carbonyl]-piperidin-4-ol (2.1 g), melting at 209° C., is obtained.",ethyl 2-phenylquinazoline-4-carboxylate | piperidin-4-ol | butyllithium | hexane | tetrahydrofuran | methanol | methylene chloride | 1-[(2-phenylquinazolin-4-yl)-carbonyl]-piperidin-4-ol | 1-[(2-phenylquinazolin-4-yl)-carbonyl]-piperidin-4-ol
US08748613B2,"(R)-Quinuclidin-3-yl 2-phenyl-2-(piperidin-1-yl)acetate (120 mg, 0.36 mmol) was dissolved in ethyl acetate (3.65 ml) and 2-bromo-1-(thiazol-2-yl)ethanone (83 mg, 0.42 mmol) was added. The mixture was stirred at room temperature for 16 hours. The solvent was evaporated and the residue was purified by flash chromatography (DCM/MeOH=95/5 to 9/1) to obtain (3R)-1-(2-oxo-2-(thiazol-2-yl)ethyl)-3-(2-phenyl-2-(piperidin-1-yl)acetoxy)-1-azoniabicyclo[2.2.2]octane bromide (125 mg, 0.234 mmol, 64.0% yield) pale brown solid.",(R)-Quinuclidin-3-yl 2-phenyl-2-(piperidin-1-yl)acetate | ethyl acetate | 2-bromo-1-(thiazol-2-yl)ethanone | DCM/MeOH | (3R)-1-(2-oxo-2-(thiazol-2-yl)ethyl)-3-(2-phenyl-2-(piperidin-1-yl)acetoxy)-1-azoniabicyclo[2.2.2]octane bromide
US07041672B2,"Following the procedure for the preparation of 5-(2,4-dichlorophenyl)-N-[(1R,2S)-2-ethoxy-2,3-dihydro-1H-inden-1-yl]-3,6-diethylpyrazin-2-amine but benzyl(3R,4S)-3-{[5-(2-chloro-4-methoxyphenyl)-3,6-diethylpyrazin-2-yl]amino}-4-hydroxypyrrolidine-1-carboxylate and making non-critical variations provided the title compound as a oil: 1H NMR (DMSO-d6) δ) 1.04, 1.16, 2.38, 2.68, 3.34, 3.40, 3.54, 3.70, 3.82, 4.18, 4.62, 5.10, 5.95, 6.98, 7.10, 7.26, 7.38; IR (diffuse reflectance) 2971, 2934, 2350 (w), 2338 (w), 2063 (w), 1949 (w), 1710 (s), 1568, 1482 (s), 1419 (s), 1397 (s), 1348, 1287, 1228, 1096, cm−1 HRMS (FAB) calcd for C29H35ClN4O4+H 539.2425, found 539.2436.","5-(2,4-dichlorophenyl)-N-[(1R,2S)-2-ethoxy-2,3-dihydro-1H-inden-1-yl]-3,6-diethylpyrazin-2-amine | benzyl(3R,4S)-3-{[5-(2-chloro-4-methoxyphenyl)-3,6-diethylpyrazin-2-yl]amino}-4-hydroxypyrrolidine-1-carboxylate | title compound"
US20140315894A1,"A mixture consisting of benzaldehyde (290 μL, 2.87 mmol, 1.0 equ.), malononitrile (190 mg, 2.87 mmol, 1.0 equ.) and triethylamine (400 μL, 2.87 mmol, 1.0 equ.) in ethanol (10 mL) was stirred for 1 min, followed by the addition of 1-methyl-3-phenyl-1H-pyrazol-5(4H)-one (500 mg, 2.87 mmol, 1 equ.). The reaction mixture was concentrated after 21 h and washed with ethanol and hexanes; re-crystallized from ethanol, and washed with hexanes and ethanol to give 6-amino-1-methyl-3,4-diphenyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile (282 mg, 8.58 mmol, 30%) as a white solid. 1H-NMR (400 MHz) DMSO: 7.41-7.38 (m, 2H), 7.28-7.24 (m, 2H), 7.21-7.18 (m, 6H), 4.88 (s, 1H), 4.77 (s, 2H), 3.83 (s, 3H), 13C-NMR (100 MHz) DMSO: 158.1, 146.0, 144.8, 144.6, 133.2, 128.7, 128.5, 127.9, 127.8, 127.1, 126.4, 120.5, 95.7, 59.9, 38.2, 34.5; LC/MS-MS: 329.1-263.1 m/z; GS1 and GS2 at 30, DP=71, CE=31, CXP=18, tR=4.00 min.","benzaldehyde | malononitrile | triethylamine | ethanol | 1-methyl-3-phenyl-1H-pyrazol-5(4H)-one | ethanol | hexanes | ethanol | hexanes | ethanol | 6-amino-1-methyl-3,4-diphenyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile"
US20020187934A1,"Methyl iodide (10 ml) was added to Boc-(D)-Met-(L)-Ala-OMe (8 g) in a mixture of DMF (20 ml) and dichloromethane (20 ml) and the mixture was allowed to stand for 16 hours and then evaporated to dryness. Further dichloromethane (2×50 ml) was added and evaporated to remove residual methyl iodide and the residue was dissolved in a mixture of DMF (300 ml) and dichloromethane (300 ml). The mixture was cooled to ˜5° C. and sodium hydride (0.76 g of an 80% dispersion in mineral oil) was added in one portion and the mixture was stirred at this temperature for 2 hours. Saturated aqueous ammonium chloride (50 ml) was added and the mixture was evaporated to dryness and then partitioned between water and ether. The ether extract was washed with brine and dried and evaporated to give a gum which was purified by flash chromatography on a sinter funnel (25% ethyl acetate:hexane to 100% ethylacetate) to give methyl (2S)-2-[(3R)-3-(N-[tert-butyloxycarbonyl]amino)-2-oxo-pyrrolidin-1-yl]propionate as a gum (4.2 g) which crystallised on standing: NMR (CDCl3): 1.4 (s, 9H), 1.4 (d, 3H), 1.8 (m, 1H), 2.6 (m, 1H), 3.4 (m, 2H), 3.7 (m, 3H), 4.2 (m, 1H), 4.9 (q, 1H), 5.2 (bs, 1H).",Methyl iodide | Boc-(D)-Met-(L)-Ala-OMe | DMF | dichloromethane | dichloromethane | methyl iodide | DMF | dichloromethane | sodium hydride | ammonium chloride | water | ether | ether | brine | hexane | ethylacetate | ethylacetate | methyl (2S)-2-[(3R)-3-(N-[tert-butyloxycarbonyl]amino)-2-oxo-pyrrolidin-1-yl]propionate
US20020058641A1,"A solution of 6-[(2,2-diphenylethyl)amino]-9H-purine-2-carbonitrile (Preparation 6) (5.0 g, 14 7 mmol) and sodium methoxide (4.0 g, 74 1 mmol) in methanol (300 ml) was heated under reflux for 24 hours. Further sodium methoxide (2 0 g, 37 mmol) and methanol (100 ml) was added and heating continued for a further 24 hours. The reaction mixture was allowed to cool and the solvent removed under reduced pressure. The residue was dissolved in tetrahydrofuran (THF) (375 ml), 2N aqueous hydrochloric acid (125 ml) added and the mixture stirred at room temperature for 24 hours. The THF was removed under reduced pressure and the suspension basified to pH 7 with saturated aqueous sodium bicarbonate solution Ethyl acetate (100 ml) was added and the white solid consisting mainly of the desired product filtered, washed with a little water and ethyl acetate and dried. Purification by column chromatography on silica gel eluting with a gradient system of dichloromethane methanol (90:10, by volume) gradually changing to dichloromethane . methanol (75 .25, by volume) afforded the title compound as a white solid, 1,25 g (25%). Evaporation of tne ethyl acetate filtrate provided 2.6 g of the starting material","6-[(2,2-diphenylethyl)amino]-9H-purine-2-carbonitrile | sodium methoxide | methanol | sodium methoxide | methanol | tetrahydrofuran | THF | hydrochloric acid | water | ethyl acetate | silica gel | dichloromethane methanol | methanol | title compound"
US20120142705A1,"A mixture of 2-(6-bromo-2-oxo-2,3-dihydro-indol-1-yl)-3-cyclopentyl-N-pyridin-2-yl-propionamide (prepared as in Example 135, 100 mg) in a 1% water in N,N-dimethyl formamide solution (2.5 mL) was degassed for 10 min by bubbling argon through it. To this reaction mixture was then added zinc cyanide (31 mg), tris(dibenzylideneacetone)dipalladium(0) (32 mg) and 1,1′-bis(diphenyl phosphino)ferrocene (26 mg) and the reaction mixture was again degassed for a period of 10 min by bubbling argon through the reaction mixture. After this time, the reaction mixture was placed in a microwave reactor and heated at 150° C. for 15 min. After this time, the reaction mixture was diluted with water (10 mL) and ethyl acetate (10 mL). The organic layer was separated dried over sodium sulfate, filtered to remove the drying agent and the filterate concentrated in vacuo. The residue was purified by column chromatography (silica gel) to afford 2-(6-cyano-2-oxo-2,3-dihydro-indol-1-yl)-3-cyclopentyl-N-pyridin-2-yl-propionamide (11 mg, 11%): LCMS ESI calcd for C22H22N4O2 (M+H)+ 375, observed 375.","2-(6-bromo-2-oxo-2,3-dihydro-indol-1-yl)-3-cyclopentyl-N-pyridin-2-yl-propionamide | water | N,N-dimethyl formamide | argon | zinc cyanide | tris(dibenzylideneacetone)dipalladium(0) | 1,1′-bis(diphenyl phosphino)ferrocene | argon | water | ethyl acetate | sodium sulfate | silica gel | 2-(6-cyano-2-oxo-2,3-dihydro-indol-1-yl)-3-cyclopentyl-N-pyridin-2-yl-propionamide"
US07425554B2,"To a solution of 2-cyclohept-1-enylphenylamine (617 mg, 3.29 mmol) in 1,2-dichlorobenzene (8 mL) was added bis(2-chloroethyl)amine hydrochloride (705 mg, 3.95 mmol), and the mixture was stirred at an external temperature of 200° C. under a nitrogen atmosphere. During the reaction, a nitrogen stream was blown into the reactor to remove the hydrogen chloride gas in the reactor. This procedure was repeated several times. After 5 hours, the reaction mixture was air-cooled to room temperature, and then aqueous solution of potassium carbonate, ethyl acetate and methanol were added to the reaction mixture and extraction was performed three times with ethyl acetate. The obtained organic layers were dried over anhydrous sodium sulfate, and then the desiccant was filtered off and the filtrate was concentrated under reduced pressure. The resultant residue was purified by NH silica gel column chromatography (ethyl acetate/heptane) to give 387 mg of the title compound as a brown oil.","2-cyclohept-1-enylphenylamine | 1,2-dichlorobenzene | bis(2-chloroethyl)amine hydrochloride | nitrogen | hydrogen chloride | potassium carbonate | ethyl acetate | methanol | sodium sulfate | resultant residue | silica gel | ethyl acetate/heptane | title compound"
US09035085B2,"To a 500 mL flask, equipped with mechanical stirrer and under inert atmosphere, was added the previously made Oxacycloundecane-2,11-dione (20 g, 108.5 mmol), phenol (10.22 g, 108.5 mmol), and 200 mL carbon disulfide. Aluminum (III) trichloride (72.34 g, 542 mmol) was added and the reaction stirred for 72 hours. Carbon disulfide was decanted away, and ice was carefully added until most of mixture was dissolved. The insoluble material was collect by suction filtration and washed with 2×100 mL of water. The solid was then dissolved in 100 mL of 1 M aqueous sodium hydroxide and then carefully acidified with 1 M aqueous hydrochloric acid until pH=7.5 The solids that formed were removed by filtration and the parent solution was continued to be acidified until pH 2.5. The crude product precipitate was collected by filtration and was washed with 1×100 mL water. The crude product was dissolved in 100 mL of 1 M aqueous sodium hydroxide and then carefully acidified with 1 M aqueous hydrochloric acid until pH=7.5 and the impurities that precipitated were filtered off. The parent solution was further acidified until pH 2. The crude product was collected by filtration and washed with 2×50 mL water. The product was recrystallized form acetone. The isolated product (1.2 g, 4%) was collected by filtration. Found: C, 69.00; H, 7.81%; C16H22O4 requires C, 69.04; H, 7.97% 1H NMR (d6-DMSO): δ 12.0, bs, 1H(COOH); δ 10.3, bs, 1H (aryl-hydroxyl); δ 7.8 d, 2H (aryl H's); δ 6.8, d, 2H, (aryl H's); δ 2.9, t, 2H(CH2 α to carbonyl); δ 2.2, t, 2H (CH2 α to COOH); δ 1.5, multiplet, 4H(CH2's β to carbonyl & β to COOH), δ 1.3, multiplet, 8H (rest of CH2's).","Oxacycloundecane-2,11-dione | phenol | carbon disulfide | Aluminum (III) trichloride | Carbon disulfide | ice | water | sodium hydroxide | crude product | product | water | crude product | sodium hydroxide | crude product | water | acetone"
US07524882B2,"The title compound was prepared following the general procedures described Example 1, Step 3 and Step 4, employing 2-chloro-4-tert-butylphenol instead of 2-chloro-4-(trifluoroethoxy)phenol for the preparation of the iodide and the intermediate prepared in Example 4, Step 1 as the phenol for coupling with the iodide.",title compound | 2-chloro-4-tert-butylphenol | phenol | iodide | intermediate | iodide
US08541592B2,"A mixture of 1-benzoyl-3-((1R,2S,4R)-5,5-difluorobicyclo-[2.2.1]heptan-2-yl)thiourea (˜1.80 mmol) and potassium carbonate (1.49 g, 10.8 mmol) in methanol (5.0 mL), water (2.5 mL), and tetrahydrofuran (2.5 mL) was stirred at ambient temperature for 2 h. The reaction mixture was concentrated in vacuo, and the residue was partitioned between EtOAc and water. The organic portion was washed with brine, conc. in vacuo, and purified by flash column chromatography (0 to 65% of ethyl acetate in hexanes) to give the title compound as a white solid. MS m/z: 207.0 (M+H)+.","1-benzoyl-3-((1R,2S,4R)-5,5-difluorobicyclo-[2.2.1]heptan-2-yl)thiourea | potassium carbonate | methanol | water | tetrahydrofuran | EtOAc | water | brine | ethyl acetate | hexanes | title compound"
US06211215B1,"A mixture of 1-[4-(4-hydroxyphenyl)butyl]-1,2,4-triazole (450 mg), 4-chloromethyl-2-(3,4-dihydro-2-naphthyl) oxazole (565 mg), potassium carbonate (290 mg) and N,N-dimethylformamide (10 ml) was stirred for 6 hours at 80° C. The reaction mixture was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water, dried (MgSO4), and concentrated. The residue was subjected to a silica gel column chromatography. A crystalline product obtained from the fraction eluted with chloroform-methanol (50:1, v/v) was recrystallized from ethyl acetate-hexane to give 1-[4-[4-[2-(3,4-dihydro-2-naphthyl)-4-oxazolylmethoxy]phenyl]butyl]-1,2,4-triazole as colorless prisms, mp 96-97° C. The yield was 49%.","1-[4-(4-hydroxyphenyl)butyl]-1,2,4-triazole | 4-chloromethyl-2-(3,4-dihydro-2-naphthyl) oxazole | potassium carbonate | N,N-dimethylformamide | water | ethyl acetate | ethyl acetate | water | MgSO4 | chloroform-methanol | ethyl acetate-hexane | 1-[4-[4-[2-(3,4-dihydro-2-naphthyl)-4-oxazolylmethoxy]phenyl]butyl]-1,2,4-triazole"
US20020107269A1,"To the stirred slurry of 3-benzooxazol-2-yl-4-chloro-phenylamine (40 mg, 0.16 mmol) and pyridine (0.038 ml, 0.48 mmol) in tetrahyrofuran (10 ml) was added propargyl chloroformate (0.032 ml, 0.32 mmol). After stirring for 30 minutes, the mixture was concentrated under vacuum. The residue was partitioned between ethyl acetate (50 ml) and a mixture of 0.5M hydrochloric acid (15 ml) and saturated aqueous sodium chloride solution (30 ml). The organic layer was dried over magnesium sulfate and concentrated under vacuum to give a solid which was recrystalized (ethyl acetate) to provide CT-32154 (44 mg, 84% yield) as a beige powder. 1H NMR (CDCl3) δ 2.55 (s, 1H, CH), 4.83 (s, 2H, CH2), 6.82 (s, 1H, NH), 7.41-7.42 (m, 2H, Ar), 7.53 (d, J=8.6 Hz, 1H, Ar), 7.87 (s, 1H, Ar), 8.18 (s, 1H, Ar).",3-benzooxazol-2-yl-4-chloro-phenylamine | pyridine | tetrahyrofuran | propargyl chloroformate | ethyl acetate | hydrochloric acid | sodium chloride | magnesium sulfate | ethyl acetate
US08816079B2,"Using (6-chloropyridazin-3-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (150 mg) described in Preparation Example 230 and 1-acetylimidazolidin-2-one (87 mg) and by the reaction and treatment in the same manner as in Example 638, the title compound (21 mg) was obtained.","(6-chloropyridazin-3-yl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone | 1-acetylimidazolidin-2-one | title compound"
US08288409B2,"In a 2-5 mL Emrys™ process vial, a mixture of the 1-formyl-4-oxo-4H-quinolizine-3-carboxylic acid (35 mg, 0.16 mmol), 4-(3,5-difluorophenyl)piperidine (45.4 mg, 0.23 mmol), glacial acetic acid (0.055 mL, 0.97 mmol) and 0.80 mL of dichloroethane was stirred vigorously. To the stirring mixture was added resin-bound MP-cyanoborohydride (20.3 mg, 0.32 mmol). The mixture was heated via Emrys Optimizer™ microwave to 120° C. for 30 minutes. The reaction was filtered, providing material, which was purified by reverse phase HPLC to yield the title compound that gave a high resolution mass spectrum (ES+) m/z of 399.1512 calculated for M+H+ [C22H20F2N2O3: 399.1515].","1-formyl-4-oxo-4H-quinolizine-3-carboxylic acid | 4-(3,5-difluorophenyl)piperidine | acetic acid | dichloroethane | cyanoborohydride | title compound"
US08765768B2,"To a solution of N′-hydroxyacetimidamide (0.081 g, 1.093 mmol) and molecular sieves 4 Å (powder, 0.3 g) in THF (3.64 mL) was added 60% sodium hydride in mineral oil (0.109 g, 2.73 mmol) at rt and the mixture was stirred at 50° C. After being stirred at 50° C. for 30 min, a solution of methyl 2-(1-(tert-butoxycarbonylamino)ethyl)-6-fluoro-3-(pyridin-2-yl)quinoline-4-carboxylate (0.233 g, 0.547 mmol) in THF (1.822 mL) was added. The mixture was heated under reflux. After 3 h, the mixture was removed by filtration though a Celite™ pad and the pad was washed with DCM (2×100 mL). The organic filtrate was washed with water (100 mL), dried over Na2SO4, filtered, and concentrated in vacuo to give tert-butyl 1-(6-fluoro-4-(3-methyl-1,2,4-oxadiazol-5-yl)-3-(pyridin-2-yl)quinolin-2-yl)ethylcarbamate as a light yellow syrup: 1H NMR (400 MHz, DMSO-d6) δ ppm 8.60 (1H, d, J=4.5 Hz), 8.28 (1H, dd, J=9.3, 5.6 Hz), 7.83-7.94 (2H, m), 7.76 (1H, dd, J=10.0, 2.7 Hz), 7.38-7.51 (2H, m), 7.18 (1H, d, J=7.2 Hz), 4.89 (1H, quin, J=6.7 Hz), 2.38 (3H, s), 1.21-1.35 (12H, m); LC-MS (ESI) m/z 450.1 [M+H]+. The light yellow syrup was carried on crude without purification for the next step.","N′-hydroxyacetimidamide | THF | sodium hydride | oil | methyl 2-(1-(tert-butoxycarbonylamino)ethyl)-6-fluoro-3-(pyridin-2-yl)quinoline-4-carboxylate | THF | DCM | water | Na2SO4 | tert-butyl 1-(6-fluoro-4-(3-methyl-1,2,4-oxadiazol-5-yl)-3-(pyridin-2-yl)quinolin-2-yl)ethylcarbamate"
US07714138B2,"A solution of tert-butyl 4-(2-(4-(2-fluoro-4-(3-(2-(4-fluorophenyl)acetyl)ureido)phenoxy)pyridin-3-yl)ethynyl)cyclohex-3-enylcarbamate (40 mg, 0.066 mol) in anhydrous 1,4-dioxane (2 mL) was cooled to −10° C. and treated with 4 M HCl/1,4-dioxane (4 mL). The mixture was stirred at −5° C. for 2.5 h then at rt for 1 h. The mixture was concentrated under vacuum without any heating to give the title compound (32 mg, 84%) as a yellow solid. 1H NMR (DMSO-d6) δ 11.05 (s, 1H), 10.61 (s, 1H), 8.69 (s, 1H), 8.44 (d, 1H, J=6.1 Hz), 8.06 (d, 1H, J=2.0 Hz), 7.80 (dd, 1H, J=12.7, 2.0 Hz), 7.46-7.38 (m, 1H), 7.35 (dd, 1H, J=8.6, 5.6 Hz), 7.19-7.13 (m, 1H), 6.82 (d, 1H, J=5.6 Hz), 6.17 (s, 1H), 3.74 (s, 2H), 3.73-3.62 (m, 2H), 3.62-3.54 (m, 1H), 3.34-3.22 (m, 1H), 2.31 (s, 1H), 1.99-1.96 (m, 1H), 1.71-1.66 (m, 1H); MS(ESI+): m/z 503.12 (M+H)+.","tert-butyl 4-(2-(4-(2-fluoro-4-(3-(2-(4-fluorophenyl)acetyl)ureido)phenoxy)pyridin-3-yl)ethynyl)cyclohex-3-enylcarbamate | 1,4-dioxane | HCl/1,4-dioxane | title compound"
US04920133,"A mixture of sodium azide (0.03 mol), ammonium chloride (0.03 mol) and 3-(4-(2-quinolinylmethyloxy)benzyl)benzonitrile (0.01 mol) in dimethylformamide (20 ml) are heated at 100° C. for 18 hours. The reaction is poured into aqueous 10% sodium hydroxide solution and washed with ethyl acetate. The crystalline product is isolated by acidification and filtration to obtain 5-(3-(4-(2-quinolinylmethyloxy)benzyl)phenyl)tetrazole.",sodium azide | ammonium chloride | 3-(4-(2-quinolinylmethyloxy)benzyl)benzonitrile | dimethylformamide | sodium hydroxide | ethyl acetate | 5-(3-(4-(2-quinolinylmethyloxy)benzyl)phenyl)tetrazole
US20130045962A1,"A solution of [(2R)-3-(2-{2-chloro-5-fluoro-6-[3-methyl-3-(1-pyrrolidinyl)-1-azetidinyl]-4-pyrimidinyl}hydrazino)-2-(cyclopentyl methyl)-3-oxopropyl](tetrahydro-2H-pyran-2-yloxy)formamide (145 mg) in 4:1 AcOH:water (20 mL) was stirred at room temperature overnight. LCMS indicated ˜45% completion of the deprotection. Another portion of the mixed solvents (4:1 AcOH:water, 20 mL) was added, and stirring continued overnight. The solvents were then removed in vacuo, and the resulting crude product was purified by RP-HPLC to provide [(2R)-3-(2-{2-chloro-5-fluoro-6-[3-methyl-3-(1-pyrrolidinyl)-1-azetidinyl]-4-pyrimidinyl}hydrazino)-2-(cyclopentylmethyl)-3-oxopropyl]hydroxyformamide (45 mg, 36%). LCMS: (M+H)+: 498.2.",[(2R)-3-(2-{2-chloro-5-fluoro-6-[3-methyl-3-(1-pyrrolidinyl)-1-azetidinyl]-4-pyrimidinyl}hydrazino)-2-(cyclopentyl methyl)-3-oxopropyl](tetrahydro-2H-pyran-2-yloxy)formamide | AcOH | water | AcOH | water | crude product | [(2R)-3-(2-{2-chloro-5-fluoro-6-[3-methyl-3-(1-pyrrolidinyl)-1-azetidinyl]-4-pyrimidinyl}hydrazino)-2-(cyclopentylmethyl)-3-oxopropyl]hydroxyformamide
US20140274930A1,"DIBAL (24.2 mL of 1.5 M, 36.4 mmol) in toluene is added dropwise over 10 min to a cold (−78° C.) solution of (3aS,6R,6aS)-6-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2,3a-trimethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one from Step IV (9.00 g, 33.1 mmol) in CH2Cl2 (90 mL). The reaction mixture is stirred at −78° C. for 2 h. Upon completion, the cold reaction mixture is quenched with 4 ml of MeOH added dropwise over 2 min and then allowed to warm to RT over 30 min. 500 ml of saturated aqueous sodium tartrate is added and the resulting slurry is stirred vigorously for 1 h at room temp. The organic phase is separated, washed with water, brine, dried over Na2SO4, filtered and concentrated to afford the title compound (22.1 g, 80.7 mmol, 98%).","DIBAL | toluene | (3aS,6R,6aS)-6-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,2,3a-trimethyldihydrofuro[3,4-d][1,3]dioxol-4(3aH)-one | CH2Cl2 | MeOH | sodium tartrate | water | brine | Na2SO4 | title compound"
US05250679,"A magnetically stirred solution of 0.848 gram of N-(2-amino-5-iodobenzoyl)-β-alanine ethyl ester (2.0 mmol), 0.35 mL 2,6-lutidine (3.0 mmol), 0.19 mL methyl iodide (3.0 mmol), and 15 mL dimethylformamide was heated to 50° C. for 15 hours. The reaction mixture was allowed to cool to room temperature and concentrated in vacuo. The resulting residue was dissolved in 75 mL ethyl acetate and washed 1×50 mL 10% citric acid, 1×50 mL sat. sodium bicarbonate, 1×50 mL brine, dried over magnesium sulfate, filtered and concentrated in vacuo. The resulting oil was further purified by column chromatography, using silica gel, eluting with a solvent gradient of 35/65 ethyl acetate/hexane to 65/35 ethyl acetate/hexane (TLC, SiO2, 1:1 EtOAc/hexane, Rf =0.84, υν positive) to yield 305 mgs (35%) of N-(2-methylamino-5-iodobenzoyl)-β-alanine benzyl ester. 1H NMR (CDCl3, dTMS) 7.56 (2H, m, Ar--H o,p-CON), 7.43 (1H, bq, 3JHH =5 Hz, NHMe), 7.38-7.32 (5H, s, ArH Ph), 6.62 (1H, bt, 3JHH =6 Hz, CONH), 6.42 (1H, d, 3JHH =9 Hz, Ar--H m-CON), 5.16 (2 H, s, OCH2), 3.64 (2H, q, 3JHH =6 Hz, NCH2), 2.81 (3H, d, 3JHH =5 Hz, NCH3), 2.64 (2H, t, 3JHH =6 Hz, CH2CO2). 13C NMR (CDCl3, δTMS) 172.4, 168.4, 148.8, 141.0, 135.5, 128.7, 128.4, 128.3, 117.3, 113.4, 74.1, 66.7, 35.2, 34.0, 29.6.","N-(2-amino-5-iodobenzoyl)-β-alanine ethyl ester | 2,6-lutidine | methyl iodide | dimethylformamide | ethyl acetate | citric acid | sodium bicarbonate | brine | magnesium sulfate | ethyl acetate/hexane | ethyl acetate/hexane | N-(2-methylamino-5-iodobenzoyl)-β-alanine benzyl ester"
US20050272709A1,"The powder of 7-morpholin-4-yl-3-oxo-2-(phenylhydrazono)-heptanenitrile (510 mg, 1.6 mmole) and hydrazine hydrate (3.2 mmole) were suspended in 20 mL of ether:THF (1:1) and stirred at ambient temperature overnight. Water was added to the reaction and the mixture was extracted with ethyl acetate. The organic extracts were washed with saline. The volumn of the organic solution was reduced which resulted in the precipitation of a yellow solid. The solution was filtered to yield 270 mg (51%) of the title compound as a yellow powder. MS (m/z, ES+): 329 (M+1, 100%); 1H NMR (ppm, 300 MHz, DMSO-d6) δ 11.58 (br s, 1H), 7.66 (m, 2H), 7.44 (m, 2H), 7.30 (m, 1H), 6.98 (br s, 2H), 3.51 (m, 4H), 2.79 (m, 2H), 2.20-2.33 (m, 5H), 1.72 (m, 2H), 1.47 (m, 2H).",7-morpholin-4-yl-3-oxo-2-(phenylhydrazono)-heptanenitrile | hydrazine hydrate | ether:THF | Water | ethyl acetate | title compound
US20100125059A1,"(3R,4R)-1-(4-iodophenyl)-3-sulfanyl-4-[4-(1,1,2,2-tetramethyl-1-silapropoxy)phenyl]azetidin-2-one (1.0 g) was dissolved in dichloromethane (10 mL), then triethylamine (1.7 mL) and 1-benzo[b]thiophen-5-yl-2-bromoethan-1-one (1.0 g) were added, and the resulted mixture was stirred at room temperature overnight. Water was added to the reaction solution and the resulted mixture was extracted with ethyl acetate. The organic layer was washed with brine, then dried over sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure and the obtained residue was purified by silica gel column chromatography (ethyl acetate/hexane=1/9) to obtain the title compound (850 mg, 63% yield). The NMR data of this compound is shown below.","(3R,4R)-1-(4-iodophenyl)-3-sulfanyl-4-[4-(1,1,2,2-tetramethyl-1-silapropoxy)phenyl]azetidin-2-one | dichloromethane | triethylamine | 1-benzo[b]thiophen-5-yl-2-bromoethan-1-one | Water | ethyl acetate | brine | sodium sulfate | silica gel | ethyl acetate/hexane | title compound"
US20020188120A1,"4-(4-methoxy-benzenesulfonyl)-1-(2-phenoxy-ethyl)-piperidine-4-carboxylic acid was prepared starting from 4-(4-methoxy-benzenesulfonyl)-1-(2-phenyl-ethoxy)-piperidine-4-carboxylic acid ethyl ester (5.0 g, 11.1 mmol) dissolved in THF:methanol 3:1 and 10 N NaOH (40 ml). The resulting reaction mixture was worked up as outlined in example 83. Yield 3.0 g (63%); off white powder; mp 235° C.; MS: 420.5 (M+H)+. Starting from 4-(4-methoxy-benzenesulfonyl)-1-(2-phenoxy-ethyl)-piperidine-4-carboxylic acid (2.5 g, 5.9 mmol) and following the procedure as outlined in example 83, 1.3 g of 4-(4-methoxy-benzenesulfonyl)-1-(2-phenoxy-ethyl)-piperidine-4-carboxylic acid hydroxyamide was isolated as an off white solid. Yield 50%; mp 168-172° C. (HCl); MS: 435.4 (M+H)+; 1H NMR (300 MHz, DMSO-d6): δ 2.3 (m, 2H), 2.5 (m, 2H), 2.9 (m, 2H), 3.4 (m, 4H), 3.5 (m, 2H), 3.7 (m,2H), 3.9 (s, 3H), 4.4 (m, 2H), 6.9-7.8 (m, 9H), 9.3 (s, 1H), 10.2 (bs, 1H), 11.3 (s, 1H).",4-(4-methoxy-benzenesulfonyl)-1-(2-phenoxy-ethyl)-piperidine-4-carboxylic acid | 4-(4-methoxy-benzenesulfonyl)-1-(2-phenyl-ethoxy)-piperidine-4-carboxylic acid ethyl ester | THF:methanol | NaOH | 4-(4-methoxy-benzenesulfonyl)-1-(2-phenoxy-ethyl)-piperidine-4-carboxylic acid | 4-(4-methoxy-benzenesulfonyl)-1-(2-phenoxy-ethyl)-piperidine-4-carboxylic acid hydroxyamide
US09062048B2,"To a solution of ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate (1.12 g, 5.24 mmol, prepared as described in Pearson, et al. in J. Org. Chem. 1997, 62(16), 5284-5292) in THF (10 mL) cooled to −78° C. under argon was added a allylmagnesium bromide (18 mL, 18 mmol, 1 M in THF) dropwise. After the complete addition, the reaction mixture was allowed to reach room temperature overnight. It was then re-cooled to −78° C. and quenched with saturated NaHCO3 solution and warmed to room temperature. After extraction with ether, the organic layer was concentrated in vacuo and the residue purified by flash chromatography (silica gel, 0-100% ether/hexanes) to afford the product.","ethyl 1,4-dioxaspiro[4.5]decane-8-carboxylate | THF | argon | allylmagnesium bromide | NaHCO3 | ether | silica gel | ether/hexanes"
US05936087,"Compound 13 was alkylated with MeI according to a general amino group alkylation procedure as follows. The 3-methoxybenzoquinoline derivative (100 mg) 13 was suspended in 5 mL of dry THF and cooled to -5° C. (ice/NaCl). 1.1 equivalents of n-butyl lithium (1 M) was added dropwise, and the reaction was stirred for 1 hour. 3 equivalents of the MeI alkylating agent was added slowly and the reaction was allowed to stir at room temperature for 2 hours. Aqueous work-up using NH4Cl and EtOAc gave a crude alkylated 3-methoxybenzoquinoline intermediate 14. Intermediate 14 was then purified by normal phase flash chromatography employing EtOAc: hexane (1:19) as the mobile phase (1HNMR: CD3Cl d 8.1 (broad d, 1H, J=8.1 Hz), 7.68(dd, 1H, J=8.1, 1.8 Hz), 7.34 (m, 2H), 6.8 (s, 1H), 3.92 (s, 3H), 3.21 (m, 2H), 2.94 (s, 3H), 2.77 (t, 2H, J=6.6 Hz), 1.92 (m, 2H)). Subsequent methoxy group deprotection by the general boron tribromide procedure described above in Example 1 resulted in the N-methyl-hydroxybenzoquinoline derivative 15.",Compound 13 | MeI | 3-methoxybenzoquinoline | THF | ice/NaCl | n-butyl lithium | MeI | NH4Cl | EtOAc | alkylated 3-methoxybenzoquinoline | Intermediate 14 | N-methyl-hydroxybenzoquinoline
US09156797B2,"To a solution of methyl 2-methyl-5-(4-morpholinyl)-1H-benzimidazole-7-carboxylate, prepared as described in Example 26, step d (0.2 g, 0.726 mmol) in N,N-Dimethylformamide (DMF) (10 mL) was added 2-methylbenzyl bromide (0.145 mL, 1.090 mmol) and potassium carbonate (0.301 g, 2.179 mmol). The resulting reaction mixture was stirred for 3 h at 80° C. The solution was cooled to room temperature and poured into water and was extracted with EtOAc. The combined organic phase was washed with Brine and concentrated. The residue was purified on a Biotage Isolera purification system using a Biotage 10 g SNAP silica gel cartridge and eluted with a gradient of DCM to 5% MeOH/DCM over 10 column volumes. The expected compound was collected and evaporated to yield a tan solid. The tan solid was dissolved in tetrahydrofuran (THF) (10.00 mL) followed by the addition of 1M lithium hydroxide solution (10 mL, 10 mmol). The reaction was stirred at 50° C. for 2 h. The reaction was cooled to room temperature and the organic solvent was removed in-vacuo. The solution was diluted with water (20 mL) and acidified with 1 N HCl. The mixture was then filtered and the grey solid was purified by reversed phase HPLC with a gradient of acetonitrile (0.1% TFA) and water (0.1% TFA v/v)(10-40%) over 10 minutes. The appropriate fractions were collected and evaporated to yield the desired product (152.6 mg, 0.418 mmol, 57.5% yield). 1H NMR (400 MHz, CHLOROFORM-d) δ ppm 2.45 (s, 3H) 2.87 (s, 3H) 3.00 (br. s., 4H) 3.72-3.81 (m, 4H) 5.53 (s, 2H) 6.60 (d, J=7.58 Hz, 1H) 6.78 (d, J=1.26 Hz, 1H) 7.14 (t, 1H) 7.23-7.33 (m, 3H). MS(ES+) m/e 365.8 [M+H]+.","methyl 2-methyl-5-(4-morpholinyl)-1H-benzimidazole-7-carboxylate | N,N-Dimethylformamide | 2-methylbenzyl bromide | potassium carbonate | water | EtOAc | Brine | DCM | MeOH/DCM | expected compound | tetrahydrofuran | lithium hydroxide | water | acetonitrile | TFA | water | desired product"
US09126998B2,"1.3 g of tert-butyl 4-oxo-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate (Example 159A, 4 mmol, 1 equivalent) were initially charged in 12.6 ml of ethanol, and 4.6 g of ammonium acetate (59.5 mmol, 15 equivalents) and 0.3 g of sodium cyanoborohydride (4.8 mmol, 1.2 equivalents) were added. The reaction mixture was divided and each portion was irradiated in a microwave oven at 130° C. for 1 min. The mixture was then concentrated and the residue was taken up in ethyl acetate and washed with water. The organic phase was dried over sodium sulphate, filtered and concentrated. The crude product obtained was purified on silica gel (mobile phase: dichloromethane/ethyl acetate: 5/1, then dichloromethane/methanol:10/1). This gave 0.84 g (78% of theory) of the title compound.","tert-butyl 4-oxo-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate | ethanol | ammonium acetate | sodium cyanoborohydride | water | sodium sulphate | crude product"
US20150050236A1,"A flame-dried round-bottomed flask was charged with diyne 12 (340 mg, 2.10 mmol), THF (15 mL) and cooled to −78° C. nBuLi (0.84 mL, 2.5 M in Hexanes, 2.10 mmol) was added dropwise over 1 min. and the reaction was stirred for 20 min. at −78° C. BF3.Et2O (0.26 mL, 2.11 mmol) was then added and the reaction was stirred for a further 20 min. at −78° C. A solution of tosylepoxide 10 (74.5 g, 0.291 mmol) was then added and the reaction was allowed to warm to room temperature. After stirring for 1 h, the reaction was quenched with H2O (20 mL) and extracted with Et2O (4×20 mL). The combined organic layers were washed with brine (30 mL) and dried (MgSO4). Column chromatography on silica gel (2:3 EtOAc:Hexanes) followed by concentration in vacuo yielded diynol 14 (31.4 mg, 0.0751 mmol, 26%) as a colourless, transparent liquid. Rf=0.43 (1:2 EtOAc:Hexanes). Spectral data for 14: 1H NMR (CDCl3, 400 MHz): δ 7.83 (AA′XX′, 2H), 7.34 (AA′XX′, 2H), 4.60 (m, 1H), 3.82 (dt, 1H, J=6.0, 4.6 Hz), 3.12 (m, 2H), 2.45 (s, 3H), 2.35 (m, 2H), 2.16 (tt, 2H, J=7.0, 2.4 Hz), 1.28-1.83 (m, 13H), 0.81-0.96 (m, 6H). 13C NMR (CDCl3, 100 MHz): δ 144.8, 134.0, 129.8, 127.9, 85.8, 81.0, 77.9, 75.3, 73.7, 70.0, 31.7, 28.9, 28.8, 28.7, 23.84, 23.81, 22.6, 21.8, 18.7, 14.1, 9.8, 9.5. IR (neat, cm−1): 3389 (br, m), 2955 (m), 2931 (s), 2857 (m), 1716 (m), 1598 (m), 1463 (m), 1363 (s), 1176 (s), 1097 (w). [α]D2°=7.5 (c 0.04; CH2Cl2).",12 | 10 | THF | nBuLi | BF3.Et2O | Et2O | H2O | brine | MgSO4 | silica gel | 14
US04279819,2-[[[5-(Dimethylamino)methyl-2-furanyl]methyl]thio]ethanamine (2.14 g) and isopropylisocyanate (0.89 g) were dissolved in acetonitrile and allowed to stand overnight. Solvents were removed and the residue recrystallised from methanol:ether to give N-[2-[[[5-(dimethylamino)methyl-2-furanyl]methyl]thio]ethyl]-N'-(1-methylethyl)urea as crystals m.p. 65°-67° (2.8 g).,2-[[[5-(Dimethylamino)methyl-2-furanyl]methyl]thio]ethanamine | isopropylisocyanate | acetonitrile | methanol | ether | N-[2-[[[5-(dimethylamino)methyl-2-furanyl]methyl]thio]ethyl]-N'-(1-methylethyl)urea
US05374720,"The same procedure as in Example 1-1 was carried out by using p-nitrobenzyl (1R,5S,6S)-2-diphenoxyphosphoryloxy-6-[(R)-1-hydroxyethyl]-1-methyl-1-carbapen-2-em-3-carboxylate(500 mg, 0.84 mmol) and (2S,4S)-4-mercapto-2-(N-methyl-2,5-dioxopyrrolidin-3-yl)-N-(p-nitrobenzyloxycarbonyl)pyrrolidine diastereomer A (330 mg, 0.84 mmol, compound of Reference Example 8) to obtain p-nitrobenzyl (1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-methyl-2-[(2S,4S)-2-(N-methyl-2,5-dioxopyrrolidin-3-yl)-N-(p-nitrobenzyloxycarbonyl)pyrrolidin-4-ylthio]-1-carbapen-2-em-3-carboxylate diastereomer A (311 mg, yield: 50.1%).","p-nitrobenzyl (1R,5S,6S)-2-diphenoxyphosphoryloxy-6-[(R)-1-hydroxyethyl]-1-methyl-1-carbapen-2-em-3-carboxylate | (2S,4S)-4-mercapto-2-(N-methyl-2,5-dioxopyrrolidin-3-yl)-N-(p-nitrobenzyloxycarbonyl)pyrrolidine | p-nitrobenzyl (1R,5S,6S)-6-[(R)-1-hydroxyethyl]-1-methyl-2-[(2S,4S)-2-(N-methyl-2,5-dioxopyrrolidin-3-yl)-N-(p-nitrobenzyloxycarbonyl)pyrrolidin-4-ylthio]-1-carbapen-2-em-3-carboxylate"
US08349836B2,"A mixture of 6-bromo-2,3-dihydro-phthalazine-1,4-dione (42.8 g, 178 mmol) in POCl3 (300 mL) was heated at reflux for 3 h. The mixture was allowed to cool and concentrated. The residue was taken up in EtOAc (400 mL) and water (200 mL), and neutralized with sodium bicarbonate. The layers were separated, aqueous layer was extracted with EtOAc (3×200 mL), and combined organic layers were dried over anhydrous sodium sulfate and concentrated. The residue was dissolved in dioxane (300 mL) and 2N NaOH (250 mL). The mixture was heated at 50° C. for 30 min, poured into water (3 L), and stirred for 15 min. Solid was filtered and dried in vacuum at room temperature to give title compound as a greenish solid (12.0 g, 24.3%). M/z (M+1)=259.32.","6-bromo-2,3-dihydro-phthalazine-1,4-dione | POCl3 | EtOAc | water | sodium sulfate | dioxane | title compound"
US07511072B2,"To a solution of (3R)-3-[4-chloro-7-(cyclopropanecarbonyl-amino)-1-oxo-1,3-dihydro-isoindol-2-yl]-3-(3-ethoxy-4-methoxy-phenyl)-propionic acid methyl ester (3.0 g, 6.2 mmol) in THF (60 ml) was added NaOH (10N, 1.2 ml, 12 mmol). The mixture was stirred at room temperature overnight. To it was added water (50 ml). The mixture was extracted with EtOAc (50 ml×2). The aqueous layer was acidified by conc. HCl until pH=6. The resulted cloudy mixture was extracted with EtOAc (50 ml×2). The organice layer washed with water (30 ml×2), brine (30 ml), dried over Na2SO4, filtered and concentrated in vacuo to give (3R)-3-[4-chloro-7-(cyclopropanecarbonyl-amino)-1-oxo-1,3-dihydro-isoindol-2-yl]-3-(3-ethoxy-4-methoxy-phenyl)-propionic acid as a white solid (2.8 g, 99%): mp, 1118-120° C., 1H NMR (CDCl3) δ 0.86-0.91 (m, 2H, c-CH2), 1.05-1.11 (m, 2H, c-CH2), 145 (t, J=7.0 Hz, 3H, OCH2CH3), 1.65-1.70 (m, 1H, c-CH), 3.13 (dd, J=6, 15 Hz, 1H, CHH), 3.23 (dd, J=10, 15 Hz, 1H, CHH), 3.86 (s, 3H, OCH3), 4.00-4.11 (m, 3H, NCHH+OCH2CH3), 4.32 (d, J=18 Hz, 1H, NCHH), 5.80-5.86 (m, 1H, CHN), 6.83-6.92 (m, 3H, Ar), 7.35 (d, J=9 Hz, 1H, Ar), 8.41 (d, J=9 Hz, 1H, Ar), 10.39 (s, 1H, NHCO). 13C NMR (CDCl3): δ 8.4, 8.5, 14.7, 16.1, 36.7, 45.9, 51.8, 55.9, 64.6, 111.5, 112.4, 118.9, 119.0, 1198, 121.9, 130.1, 132.9, 136.7, 139.0, 148.7, 149.5, 168.7, 172.8, 173.8; Anal Calcd for C24H25ClN2O6+0.37H2O: C, 60.11; H, 5.41; N, 5.84. Found: C, 60.11; H, 5.25; N, 5.64, H2O, 1.40.","(3R)-3-[4-chloro-7-(cyclopropanecarbonyl-amino)-1-oxo-1,3-dihydro-isoindol-2-yl]-3-(3-ethoxy-4-methoxy-phenyl)-propionic acid methyl ester | (3R)-3-[4-chloro-7-(cyclopropanecarbonyl-amino)-1-oxo-1,3-dihydro-isoindol-2-yl]-3-(3-ethoxy-4-methoxy-phenyl)-propionic acid | THF | NaOH | water | EtOAc | EtOAc | water | brine | Na2SO4"
US20150031685A1,"To a solution of methyl 2-(1-methyl-2,2-dioxido-1,3-dihydrobenzo[c]isothiazol-6-yl)acetate (0.42 g, 0.0016 moles) in MeOH (15 ml) was added 10% aqueous sodium hydroxide solution (15 ml) at 0° C. The reaction mixture was then stirred at room temperature for 2 hours. After completion of the reaction, the solvent was removed in vacuo, the residue was dissolved in water and extracted with ethyl acetate twice. The aqueous layer was cooled to 0° C. and acidified to pH 2 with 3N AqHCl. The precipitated solid was filtered and washed with water and dried get pure 2-(2,2-dioxido-1,3-dihydrobenzo[c]isothiazol-6-yl)acetic acid (0.27 g).","methyl 2-(1-methyl-2,2-dioxido-1,3-dihydrobenzo[c]isothiazol-6-yl)acetate | MeOH | sodium hydroxide | water | ethyl acetate | water | 2-(2,2-dioxido-1,3-dihydrobenzo[c]isothiazol-6-yl)acetic acid"
US20150307493A1,"A solution of methyl(2-chloro-4-fluorophenyl)acetate (100 mg, 0.5 mmol) (Acros Organics cat#30478) and N-bromosuccinimide (90 mg, 0.5 mmol) in carbon tetrachloride (0.7 mL) was heated to 100° C. for 1 h. The reaction mixture was cooled to room temperature, filtered, and partitioned between ethyl acetate and water. The combined organic layers were washed with brine, dried over MgSO4, filtered, and concentrated to afford crude methyl bromo(2-chloro-4-fluorophenyl)acetate as light yellow semi solid (120 mg, 90%).",methyl(2-chloro-4-fluorophenyl)acetate | N-bromosuccinimide | carbon tetrachloride | ethyl acetate | water | brine | MgSO4 | methyl bromo(2-chloro-4-fluorophenyl)acetate | solid
US20080027041A1,"A mixture of 4-(4-methoxy-2-methyl-phenyl)-4-oxo-butyric acid (2 g, 9 mmol), acetic acid (30 mL) and 48% aqueous HBr (10 mL) was heated at 130° C. for 5.5 h. The reaction was cooled to rt and concentrated at reduced pressure and azeotrope twice with benzene to give a crude residue. The crude residue was dissolved in ethanol (25 mL) and added amberlyst then heated at 90° C. for 18 h. The reaction was filtered over celite and evaporated ethanol at reduced pressure then quenched with water and extracted twice with methylene chloride to obtain 4-(4-hydroxy-2-methyl-phenyl)-4-oxo-butyric acid ethyl ester (1.6 g, 75%). The crude material was used for the next reaction without purification. Step 2",4-(4-methoxy-2-methyl-phenyl)-4-oxo-butyric acid | acetic acid | HBr | benzene | crude residue | crude residue | ethanol | ethanol | water | methylene chloride | 4-(4-hydroxy-2-methyl-phenyl)-4-oxo-butyric acid ethyl ester
US04540690,"A mixture of 2-[4-(trifluoromethyl)benzoyl]cyclohexanone, 5.4 g, 0.02 mole, with 2.28 g, 0.04 mole of azetidine and 25 mg of p-toluenesulfonic acid in 50 ml of benzene was refluxed for 17 hr using a Soxhlet device containing 50 g of 3A molecular sieves. The resulting solution was evaporated, the residue was dissolved in 75 ml of ethanol and hydrogenated in the presence of 0.5 g of platinum dioxide (PtO2) at an initial pressure of 54 psig for 1.5 hr. The mixture was filtered, cooled in ice and treated with 5.4 g of sodium borohydride (NaBH4) and stirred at room temperature for 16 hr. The mixture was then evaporated, the residue taken up in a water/diethyl ether mixture, the ether extract being separated and washed with saturated sodium chloride solution, dried with magnesium sulfate and evaporated. Trituration of the residue with diethyl ether gave 0.76 g (plus filtrate) of the N-[2-[[4-(trifluoromethyl)phenyl](hydroxy)methyl] cyclohexyl]azetidine as a colorless solid, mp 163°-165° C., which was raised to 167°-168° C. on recrystallization from methanol. The UV λmax(ε)216(9,550), 252(382), 258(442), 263(411), 258(307). The IR and Mass spectral analyses were consistent. The NMR (CDCl3) indicated that the product contained a mixture of two diastereoisomers. δ7.6-7.4(m,5H,aromatic) 5.1(m,1H, HC--O), 2.7(m,1H, CH--N), 2.2-1.9(m,3H, CH--C--O and C--CH2 --C of azetidine), 1.9-0.9(m,8H, CH2 's).",2-[4-(trifluoromethyl)benzoyl]cyclohexanone | azetidine | p-toluenesulfonic acid | benzene | 3A | ethanol | platinum dioxide | ice | sodium borohydride | diethyl ether | ether | sodium chloride | magnesium sulfate | N-[2-[[4-(trifluoromethyl)phenyl](hydroxy)methyl] cyclohexyl]azetidine
US20140121213A1,"BF3.Et2O (53.8 g, 378.8 mmol) was added dropwise over 15 min to a cooled (−40° C.) solution of HC(OEt)3 (51.0 g, 344.4 mmol) in CH2Cl2 (200 mL). Stirring was continued for 10 min at −40° C. then the solution was transferred to an ice-water bath and stirred at 0° C. for 20 min. The mixture was cooled to −78° C., and acetone (10.0 g, 172.2 mmol) added followed by dropwise addition of i-Pr2NEt (66.7 g, 516.5 mmol) over 30 min. Stirring was continued for 1 h then the solution was poured onto a vigorously stirred mixture of saturated NaHCO3 (200 mL) and CH2Cl2 (300 mL). The organic phase was separated, washed with ice-cold 1 N H2SO4 (200 mL×2) and brine (200 mL), dried over Na2SO4 and evaporated, the residue oil was purified by distillation under reduced pressure (1 mm Hg, 78-82° C.) to give the title compound. (19.5 g, 70.7%) as a colorless oil. This was used in the next step.",BF3.Et2O | HC(OEt)3 | CH2Cl2 | ice-water | ice | acetone | i-Pr2NEt | NaHCO3 | CH2Cl2 | brine | Na2SO4 | title compound
US08765746B2,"To a mixture of 3-[amino(4-chlorophenyl)methyl]-4-cyano-5-(morpholin-4-yl)thiophene-2-carboxylic acid.HCl (0.206 g, 0.497 mmol), 1-Hydroxybenzotriazole hydrate (92.1 mg, 0.601 mmol) and N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (188 mg, 0.981 mmol) in dry Methylene chloride (10.0 mL, 156 mmol) was added N,N-Diisopropylethylamine (0.252 mL, 1.45 mmol). The resulted clear solution was stirred at r.t. for 21 hours. The reaction solution was diluted with DCM (−30 mL), washed with water (3×), brine, dried over anhydrous Na2SO4, filtered and rotavaped to give a crude product. Chromatograph in a silica gel column using MeOH/DCM (0/100 to 3/97) afforded a racemic product (0.138 g, yield 74.8%).","3-[amino(4-chlorophenyl)methyl]-4-cyano-5-(morpholin-4-yl)thiophene-2-carboxylic acid | HCl | 1-Hydroxybenzotriazole hydrate | N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride | Methylene chloride | N,N-Diisopropylethylamine | DCM | water | brine | Na2SO4 | crude product | product | MeOH/DCM"
US20080167303A1,"Cesium carbonate (0.29 g, 0.9 mmol) was added to a solution of 1-(4-chlorophenyl)-1,3-dihydro-2,1,3-benzothiadiazole2,2-dioxide (Made analogously as in general procedure I, 0.25 g, 0.9 mmol), and 1,4-dibromobutane (0.42 mL, 3.6 mmol) in dry DMF (5.0 mL) under nitrogen. After 3 h, the reaction mixture was diluted with diethyl ether and washed with water and brine. The ether layer was dried over magnesium sulfate, filtered and concentrated in vacuo to give 0.41 g of crude product. The crude product was pre-adsorbed onto Celite and purified via Isco chromatography (Redisep, silica, gradient 5-30% ethyl acetate in hexane) to afford 0.22 g (59%) of 1-(4-bromobutyl)-3-(4-chlorophenyl)-1,3-dihydro-2,1,3-benzothiadiazole2,2-dioxide.","Cesium carbonate | 1-(4-chlorophenyl)-1,3-dihydro-2,1,3-benzothiadiazole2,2-dioxide | 1,4-dibromobutane | DMF | diethyl ether | ether | water | brine | magnesium sulfate | crude product | crude product | silica | ethyl acetate | hexane | 1-(4-bromobutyl)-3-(4-chlorophenyl)-1,3-dihydro-2,1,3-benzothiadiazole2,2-dioxide"
US07238714B2,"The title compound was prepared according to the procedure described in step 1 of Example 67 from methyl 5-chloro-2-fluorobenzoate and 2,3-difluorophenol: 1H-NMR (CDCl3) δ 7.94 (1H, d, J=2.6 Hz), 7.47 (1H, dd, J=8.7, 2.6 Hz), 7.05–6.86 (3H, m), 6.72–6.60 (1H, m), 3.85 (3H, s).","title compound | methyl 5-chloro-2-fluorobenzoate | 2,3-difluorophenol"
US08552028B2,"Scheme 1 (FIG. 1): Protection of the hydroxyl group in vanillin with benzyl bromide yielded aldehyde 1 is shown in Scheme 1. Henry reaction between aldehyde 1 and nitromethane gave nitrostyrene 2. Reduction of compound 2 with lithium aluminum hydride in tetrahydrofuran (THF) afforded amine 3. The reaction of amine 3 with an excess amount of methyl formate provided formamide 4. Cyclization of amide 4 using phosphorus oxychloride (POCl3) via Bischler-Napieralski reaction obtained 3,4-dihydroisoquinoline 5. Alkylation of compound 5 with iodopropane followed by NaBH4 reduction produced tetrahydroisoquinoline 6 in high yield. Catalytic hydrogenation over Pd/C removed the protective groups of 6 to afford 1,2,3,4-tetrahydroisoquinolin-7-ol 7 in quantitative yield. Treatment of compound 7 with Pb(OAc)4 in acetic acid followed by acid-catalyzed aromatic substitution with 1,3-dimethoxybenzene using trifluoroacetic acid (TFA) furnished 8-phenyl-tetrahydroisoquinolin-7-ol 8.","Pd/C | 1,2,3,4-tetrahydroisoquinolin-7-ol | compound 7 | Pb(OAc)4 | acetic acid | 1,3-dimethoxybenzene | trifluoroacetic acid | 8-phenyl-tetrahydroisoquinolin-7-ol"
US20120149718A1,"A solution of (5-{[(2-methoxy-ethyl)-methyl-amino]-methyl}pyrazin-2-yl) carbamic acid tert-butyl ester (382 mg, 1.3 mmol) in CH2Cl2 (40 mL) was added TFA (4 mL) and the reaction mixture was stirred at room temperature for 2 h and then concentrated in vacuo. The residue was dissolved in CH2Cl2, poured onto saturated aqueous NaHCO3 and extracted 3 times into CH2Cl2. The combined extracts were dried over Na2SO4 and concentrated in vacuo to afford 5-{[(2-methoxyethyl)-methylamino]-methyl}-pyrazin-2-ylamine (98 mg, 38%): 1H NMR (300 MHz, CHLOROFORM-d) δ ppm 2.33 (s, 3H) 2.67 (t, J=5.75 Hz, 2H) 3.35 (s, 3H) 3.54 (t, J=5.75 Hz, 2H) 3.63 (s, 2H) 4.55 (br. s., 2H) 7.97 (d, J=1.32 Hz, 1H) 8.04 (d, J=1.51 Hz, 1H).",(5-{[(2-methoxy-ethyl)-methyl-amino]-methyl}pyrazin-2-yl) carbamic acid tert-butyl ester | CH2Cl2 | TFA | CH2Cl2 | NaHCO3 | CH2Cl2 | Na2SO4 | 5-{[(2-methoxyethyl)-methylamino]-methyl}-pyrazin-2-ylamine
US20030078270A1,"Using General Procedure D; [1 -(4-bromophenyl)-cyclopropyl ]-dipropylamine (Intermediate 121, 150.0 mg, 0.50 mmol) in triethylamine (5 mL) was treated with copper(I)iodide (10.0 mg, 0.05 mmol) and then sparged with argon for 5 minutes. Trimethylsilyl acetylene (0.70 g, 7.1 mmols) was then added followed by dichlorobis(triphenylphosphine)palladium(II) (35.0 mg, 0.05 mmol). The resulting reaction mixture was heated to 70° C. for 5d. The title compound was isolated by chromatography (0-3% EtOAc—hexanes).",[1 -(4-bromophenyl)-cyclopropyl ]-dipropylamine | Intermediate 121 | triethylamine | copper(I)iodide | argon | Trimethylsilyl acetylene | dichlorobis(triphenylphosphine)palladium(II) | 5d | title compound | EtOAc—hexanes
US20030018046A1,"To a stirred solution of 1-(2-trimethylsilylethoxymethyl)-2-formyl-benzimidazole (prepared as described by Bridger et al. U.S. patent application U.S. Ser. No. 09/535,314) (0.150 g, 0.54 mmol) in dry MeOH (2.5 mL) was added a dry MeOH (2.5 mL) solution of N′-(1H-benzimidazol-2-ylmethyl)-N′-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-benzenedimethanamine (0.215 g, 0.54 mmol) under an argon atmosphere. The mixture was stirred at room temperature for 1.5 h then concentrated under reduced pressure and analyzed by 1H NMR. The residue was dissolved in dry MeOH (5 mL) and to the resultant solution was added sodium borohydride (41 mg, 1.08 mmol) and the reaction mixture stirred for 16 h (see General Procedures XX). Purification of the crude product by radial chromatography on a 2 mm TLC grade silica gel plate (CH2Cl2/MeOH/NH4OH, 100:1:1 followed by 50:1:1) afforded the desired product (0.165 g, 47%) as a pale yellow oil.","1-(2-trimethylsilylethoxymethyl)-2-formyl-benzimidazole | MeOH | MeOH | N′-(1H-benzimidazol-2-ylmethyl)-N′-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-benzenedimethanamine | argon | MeOH | resultant solution | sodium borohydride | crude product | silica gel | CH2Cl2/MeOH/NH4OH | desired product"
US05464829,"Using 306 mg of p-methoxybenzyl 7-[(Z)-2-(2-tritylaminothiazol-4-yl)-2-{(S)-1-diphenylmethoxycarbonylethoxyimino}acetamido]-3-chloromethyl-3-cephem-4-carboxylate in place of p-methoxybenzyl 7-{(Z)-2-(2-tritylaminothiazol-4-yl)-2-methoxyiminoacetamido}-3-chloromethyl-3-cephem-4-carboxylate and 56 mg of 2-mercaptothiazolo[4,5-c]pyridine, the reaction and purification were carried out in the same manner as in Example 1(a) to obtain 276 mg of the title compound in a yield of 80%.","p-methoxybenzyl 7-[(Z)-2-(2-tritylaminothiazol-4-yl)-2-{(S)-1-diphenylmethoxycarbonylethoxyimino}acetamido]-3-chloromethyl-3-cephem-4-carboxylate | 2-mercaptothiazolo[4,5-c]pyridine | title compound"
US06727264B1,"Prepared by Procedure A and Scheme AN using N-(3-{1-[3-(4- fluorophenyl)-3-hydroxypropyl]-4-piperidinyl}phenyl)-2-methylpropanamide and 3,4-dichlorophenol: ESMS m/e: 542.7 (M+H)+.","N-(3-{1-[3-(4- fluorophenyl)-3-hydroxypropyl]-4-piperidinyl}phenyl)-2-methylpropanamide | 3,4-dichlorophenol"
US08383652B2,"0.7 g (16.5 mmol) of sodium hydride are added portionwise to a solution at 0° C. of 3.9 g (16.5 mmol) of methyl (diethoxyphosphoryl)methoxyacetate in 45 mL of tetrahydrofuran. The reaction mixture is stirred for 45 minutes at room temperature, followed by dropwise addition of 3.4 g (11.8 mmol) of 3-butoxy-4-iodobenzaldehyde (prepared as described in Example 19g) in 30 mL of tetrahydrofuran. The reaction is slightly exothermic and the reaction mixture is maintained at a temperature of 25-27° C. with an ice bath. When the temperature has stabilized, the reaction mixture is stirred for 20 hours at room temperature. The reaction is worked up by addition of 60 mL of water and extraction with ethyl acetate. The organic phases are combined, washed with saturated sodium chloride solution and then dried over magnesium sulfate. The solvents are evaporated off. The crude product obtained is purified by chromatography on a column of silica eluted with a 98/2 heptane/ethyl acetate mixture. 1.5 g (33%) of the isomer methyl (Z)-3-(3-butoxy-4-iodophenyl)-2-methoxyacrylate are obtained in the form of a yellow solid and 1.0 g of the isomer (E)-3-(3-butoxy-4-iodophenyl)-2-methoxyacrylate are obtained in the form of a pale yellow oil.",sodium hydride | methyl (diethoxyphosphoryl)methoxyacetate | tetrahydrofuran | 3-butoxy-4-iodobenzaldehyde | tetrahydrofuran | ice | water | ethyl acetate | sodium chloride | magnesium sulfate | crude product | silica | heptane/ethyl acetate | methyl (Z)-3-(3-butoxy-4-iodophenyl)-2-methoxyacrylate | (E)-3-(3-butoxy-4-iodophenyl)-2-methoxyacrylate
US20050065118A1,"As described in Example 1, the title compound was prepared from 3,4-dichlorobenzenisothiocyanate (120 mg) and N-aminobenzo[3,4-c]1,2,5-oxadiazol-5-ylcarboxamide (88 mg). The title compound had the following physical properties: mp 315-317° C.; LC-MS 364.1.","title compound | 3,4-dichlorobenzenisothiocyanate | N-aminobenzo[3,4-c]1,2,5-oxadiazol-5-ylcarboxamide | title compound"
US05965692,"A mixture of 2,5-dioxo-1,4-dioxane (2.02 g; 17.4 mmol) and di-n-propylamine (5 ml; 36.5 mmol) was heated at 50° C. for 1 h and at 90° C. for 66 h. Toluene was added and subsequently removed in vacuo with excess di-n-propylamine. The residue was purified by flash chromatography using 10% methanol in methylene chloride as eluent to give 4.18 g (66%) of the desired compound.","2,5-dioxo-1,4-dioxane | di-n-propylamine | Toluene | di-n-propylamine | desired compound"
